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CHAPTER 1 INTRODUCTION
1.1 Background on Dinuclear Metal Complexes: Design, Types, and Applications.
During the last decade, there has been a significant interest in the chemistry of
dinuclear and polynuclear metal complexes inspired, in part, by the discovery of multitude
of such species in metalloenzymes.1 Dinuclear complexes have the ability to induce a
diverse set of chemical transformations that are inaccessible in mononuclear systems
due, in part to: (1) ability to catalyze multielectron transformations; (2) ability to bind and
activate a substrate in a cooperative fashion between the metals.2,3 An extensive
research on dinuclear metal complexes resulted in their application to many different uses
in catalysis, activation of small molecules, and sensing of physiologically relevant
species.1-4
Dinucleating ligands can be designed with the desired application in mind. The
nature of the ligand can have profound effects on the metal - metal distance in the
resulting dinuclear metal complex, on the types of metals that can coordinate at each
chelating site, and therefore on the interaction between the metals.5 These factors are
crucial to the design of the bimetallic metal complexes and their ability to perform their
desired function. In particular, the distance between the metals is crucial to the nature of
the substrate that can be bound and activated between the metals. The most common
example of dinucleating ligands are ligands that support metal–metal bonds.6. There is a
significant number of such complexes in the literature, both homobimetallic and
heterobimetallic.

Generally,

homobimetallic

complexes

are

supported

by

homodinucleating ligands whereas heterodinuclear complexes are made possible by
heterodinucleating ligands that feature two different sites.
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Figures 1.1 and 1.2 below demonstrate two examples of dinuclear metal
complexes, supported by dinucleating ligands, that feature metal-metal bonds. The
example in Figure 1.1 presents a homodinuclear complex prepared by Theopold and
coworkers that contains a quintuply bonded Cr-Cr species that is capable of activating a
series of alkynes across the metal-metal bond.7 Figure 1.2 shows an example of a
heterodinuclear metal complex (synthesized by Thomas and coworkers) that combines
an early (zirconium) and a late (cobalt) metals.8 The combination of early and late metals
leads to an exciting reactivity in the reductive splitting of CO2. The products of the
reductive splitting bind to the dinuclear complex: the [O] is bridging both metals, whereas
CO binds to the late “CO”-philic metal, cobalt(I).

Figure 1.1 A homodinuclear Cr complex capable of activating alkynes.
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Figure 1.2. Reaction of a heterodinuclear complex with CO2.
There is also a growing number of dinucleating ligands that support bimetallic
complexes lacking direct metal-metal interactions. Generally, it is more difficult to design
such species, as metal-metal bonds often constitute a “backbone” of a bimetallic complex.
However, a direct metal-metal interaction in a bimetallic (or multimetallic) complex can be
undesirable to its performance as, for example, in the case where the substrate or product
is expected to bind between the metals. Figure 1.3 and 1.4 demonstrate two examples
of such complexes. Figure 1.3 demonstrates a macrocyclic, relatively rigid
heterodinucleating ligand that fixes two different metals (iron and nickel) in their
respective positions; relatively large metal-metal distance allows for the binding of a
variety of substrates between these metals, including CN- and HCO2-.9 Figure 1.4 shows
an example of a heterodinuclear complex stabilized by a heterodinucleating ligand that
enables hydrogen activation.10
The examples above demonstrate that dinuclear systems are capable of unusual
and exciting reactivity, prompting further interest in the design and exploration of new
bimetallics stabilized by dinucleating ligands.
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Figure 1.3 A heterodinuclear complex without a metal-metal interaction that contains
bridging CN or HCO2 ligands 9

5

Figure 1.4 Activation of dihydrogen by a heterodinuclear metal complex (M=Na+, Li+,
B(Arf)4- counterions not shown).10
1.2 Significance of Redox Non-Innocent Ligands
As will be described below, my research focused on the design of dinucleating
ligands containing redox-active, or redox non-innocent, chelating units. For the purpose
of this dissertation, redox non-innocent are ligands that are able to accept electrons into
their p system and therefore undergo reduction.11 Many different variants of redox non-
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innocent ligands have been reported during the last decade. Figure 1.5 shows most
prominent examples of redox non-innocent ligands, that include bidentate α-diimine,
iminopyridine, and bipyridine, and tridentate bis(imino)pyridine and terpyridine.11

Figure 1.5 Examples of redox non-innocent ligands
The ability of these ligands to accept electron density was demonstrated by Chirik
and coworkers in the iron bis(imino)pyridine system (Figure 1.6).12 This system was
shown to go through a stepwise reduction from an Fe(II) dichloride complex to a Fe(II)
bis(dinitrogen) complex after reduction by two electrons. Upon addition of the first electron
to the Fe(II) dichloride complex, a four-coordinate mono-chloride Fe(II) complex was
isolated. The anionic charge is located on the ligand backbone, and is shared throughout
the p system of the ligand. This change in the charge on the ligand is evidenced through
the change in bond lengths in the ligand backbone. The changes in the C=N (imino) and
the C(imino)-C(pyridine) bonds are especially symptomatic of the change in the oxidation
state of the ligand. Thus, in the fully oxidized state, the ligand demonstrates a C=N bond
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of 1.295(7) Å and a C-C bond of 1.482(8) Å. Upon one-electron reduction, a C=N bond
becomes longer (1.313(3) Å), and a C-C bond becomes shorter (1.443(4) Å). The addition
of the second electron to the system leads to the loss of another chloride ion and
formation of the Fe(II) bis(dinitrogen) complex. This complex is still formally Fe(II) while
the bis(imino)pyridine ligand [NNN] becomes dianionic. The C=N bond undergoes further
enlongation to 1.333(2) Å and the C-C bond undergoes further contraction to 1.428(3) Å.
The ability of the redox non-innocent ligand to accept reducing equivalents within its
backbone allows for the overall metal-ligand ensemble to reach oxidation states that
would not be normally accessible for the metal alone (i. e. Zn, Al).13 Even for metals that
are capable of reaching lower oxidation states (i. e. Fe(II), Ni(II)), the reduction of metalredox active ligand complexes occurs at significantly more accessible potentials that for
the metal alone. This has been shown to lead to reactivity that would have been otherwise
impossible with certain metals, particularly base metals. For these reasons outlined
above, we have chosen to use redox non-innocent ligands for this project, specifically the
iminopyridine and bis(imino)pyridine ligands.

Figure 1.6 The redox non-innocence of bis(imino)pyridine ligands manifested by change
in bond distances (see text for details). Ar= 2,6-diisopropylphenyl
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1.3 Oxalate Sensing
A significant part of my work focuses on the design of bimetallic complexes that
can serve as efficient oxalate sensors. The efficient sensing of oxalate is of significant
importance because of its industrial and especially physiological applications.14,15 Oxalate
is a product of human metabolism.16 A typical range of oxalate in human urine is 10-30
mg/day.16 In human plasma, the normal concentration is 0.8-2.5 μmol/l. High oxalate
concentration in the body is known as hyperoxaluria and is a substantial factor in the
formation of urinary stones, kidney stones, steatorrhoea, and ileal disease.15 Thus,
accurate monitoring of oxalate concentration is of significant importance. A wide range of
oxalate

sensors

exists,

including

biosensors,

electrochemical

sensors

and

chemosensors.17 Chemosensors for oxalate are among the least expensive and most
accessible tools to detect oxalate, that generally do not require sophisticated equipment
and enable oxalate detection by a simple color change. The most successful of these are
dinuclear metal complexes.17 Figure 1.7 shows three selected examples of oxalate
sensors, along with their corresponding oxalate binding affinities.17 The dinuclear nature
of these complexes allows for the tight binding of oxalate between the metals. In addition,
a specific distance between the metals (as prescribed by the dinucleating ligand) leads
to the selectivity for oxalate versus other dicarboxylates or especially monocarboxylates
which are present in physiological samples and can compete with oxalate for metal
binding.
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Figure 1.7 Examples of previously reported oxalate sensors, and oxalate binding
constants for each sensor.17
A commonly used method for the detection of oxalate is fluorescence displacement
assay, which is depicted in Figure 1.8.17c In this method of oxalate detection, a
fluorescence indicator (typically Fluorescein or Eosin Y) is titrated into a solution
containing the dinuclear complex with the appropriate intermetallic cavity capable of
binding the indicator. Coordination of the indicator in the dinuclear cavity turns off the
fluorescence of the indicator giving a negative response. When the complex-indicator
system is titrated with oxalate, the dinuclear complex binds oxalate stronger than the
indicator thus releasing the indicator and turning the fluorescence back on. We note that
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oxalate is an excellent bridging ligand which generally out-competes other bridging
ligands given the appropriate size of the cavity. This method of detection has a high
sensitivity because of the nature of fluorescence detection. However, the need for
expensive indicators makes this a less than ideal way to sense oxalate. The design of a
system that can avoid the use of these expensive indicators is of great interest to the
community.

Figure 1.8. Fluorescence detection of oxalate.
1.4 Activation of Heteroallenes
Transition metal-mediated activation of small molecules is of enduring interest as
it provides efficient routes to their utilization as building blocks in the synthesis of larger
organic molecules, or in their transformation to fuels.5,

18

Dinuclear (or multinuclear)

systems often provide significant advantages to the mononuclear systems in the
activation of small molecules, due to several factors: (i) these are generally multielectron
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transformations and a dinuclear metal complex provides twice as many electrons
compared with a respective mononuclear one; (ii) cooperative reactivity between two
metal complexes can be achieved; (iii) most of the biological systems that activate small
molecules feature dinuclear or multinuclear assemblies (e. g. FeMoco for N2, Mo-Cu
CODH or Fe-Ni CODH for CO2).1
The research presented in this dissertation focuses in part on the design of
dinuclear complexes for the activation of carbon disulfide (CS2) as a model for CO2
reactivity. The activation of carbon dioxide is of great interest and many routes have been
taken to pursue it.19 CS2 is isoelectronic with CO2, and often displays similar
coordination/activation modes. As a substrate, CS2 is advantageous to CO2 as it is a liquid
at RT and is somewhat more reactive than CO2. Thus, we postulated that CS2 would
enable an easier screening of possible cooperative reactivity at dinuclear centers, and
that the systems capable of such reactivity could be later applied to CO2 activation.
Examples of bimetallic intermolecular and intramolecular CO2 and CS2 reductive
transformations are given below in Figure 1.9 - 1.11.

Figure 1.9 demonstrates

stoichiometric examples of the rare reductive coupling of CS2 and CO2. This reaction
results in the formation of oxalate/tetrathiooxalate.20, 21 Figure 1.9, top illustrates coupling
of two CO2 molecules by two Sm(II) complexes to yield a bridging oxalate between two
Sm(III) centers. Figure 1.9, bottom shows two Ni(I) centers reductively coupling two CS2
molecules to form tetrathiooxalate. It is of note that in both cases the metals that enable
reductive coupling of heteroallenes are strong one-electron reductants and also that the
product of the C-C bond formation reaction (oxalate and tetrathiooxalate) bridges
between the metals.
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Figure 1.9. Stoichiometeric reductive coupling of CO2 (top) and CS2 (top).21, 22
Figure 1.10 demonstrates activation of CO2 by a “heterobimetallic” system
containing Cu-BR2 reactive fragment, that reductively splits CO2 to form CO and [O]; this
bimetallic two-electron reduction is achieved by the two-electron oxidation of boryl to give
boryloxide.22 It is also worth noting the resulting “oxo” is bridging.

Figure 1.10. Splitting of CO2 by a Cu-boryl complex. Ar = 2,6-diisopropylphenyl , R =
bis(pinacolato). 22
Figure 1.11 demonstrates a rare example of the catalytic reductive coupling of
CO2 to give oxalate by a di-Cu system.23 This system, synthesized and investigated by
Bouwman and coworkers, is able to perform 7 turnovers in 24 hours. This process is
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electrocatalytic: electrochemical reduction of the Cu(II) centers enable release of the
oxalate which is extracted as H2C2O4 (or Li2C2O4) during this process. This system is
clearly very significant, Since it is the first example of homogeneous well-understood
reductive coupling of CO2. It is worth mentioning however that the reductive coupling
occurs intermolecularly (to form the bis(oxalate) tetrametallic product) rather than
intramolecularly (to form the mono(oxalate) bimetallic product) which may explain a
relatively low reactivity of this system in CO2 reduction.

Figure 1.11. Catalytic reductive coupling of CO2 to Oxalate by a tetra-Cu catalyst.
The examples above demonstrate that: (i) one-electron reductants lead primarily
to the one-electron reductive coupling whereas two-electron reagents enable reductive
splitting; (ii) most of the products are dinuclear. Based on these observations, we
postulated that dinuclear systems featuring a (1) sufficiently reducing metal centers
(either one-electron or two-electron reductants), and (2) metal-metal distance allowing

14

oxalate/tetrathiooxalate coordination, may be beneficial in the reduction of CS2 (or CO2).
As noted earlier, my research focused primarily on the exploration of the reactivity of
bimetallic complexes with CS2, and the comparison of their reactivity with the accurate
mononuclear analogues.
1.4 Research Goals and Objective:
This research is focused on two major goals. The first goal is to develop new
sensors for a biologically relevant substrate, oxalate, using new bimetallic platforms. The
second goal of my research is to develop new bimetallic systems that are capable of
binding heteroallenes, and to investigate their reactivity toward the reductive coupling of
CS2.
To achieve these goals, specific objectives (1-4) were pursued:
1. Design and synthesis of the flexible open-chain dinucleating ligands and their
corresponding non-oxophilic late metal complexes.
2. Design and synthesis of the rigid macrocyclic dinucleating ligands and their
corresponding non-oxophilic late metal complexes.
3. Investigating of the reactivity of the above dinuclear complexes in oxalate sensing,
with particular emphasis on the comparison of the reactivity of the flexible
bimetallics and rigid bimetallics featuring comparable inter-metallic distances
4. Investigation of the reactivity of dinuclear complexes with CS2.
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CHAPTER 2 RECYCLABLE CHEMOSENSOR FOR OXALATE BASED ON
BIMETALLIC COMPLEXES OF A OPEN-CHAIN FLEXIBLE DINUCLEATING
BIS(IMINOPYRIDINE) LIGAND
Portions of this chapter were reprinted or adopted from: Beattie, J.W.; Bheemaraju, A.;
White, D.S.; Martin, P. D.; Groysman, S., Dalton Trans. 2014, 49, 7979-7986.24 All rights
to this work are retained by the authors and any reuse requires the permission of the
authors.
2.1 Introduction
The ability of a system to ”sense” oxalate is determined by several factors. These
factors include the distance between the metal centers, the nature of the interaction of
the chosen metal centers with the oxygen atoms of oxalate, the selectivity of the system
for oxalate versus other competing carboxylates, and the availability of an analytical tool
that can quantify the binding of oxalate to the system. To satisfy these criteria we have
designed a system comprised of a dinuclear di-Ni (or di-Cu) complex of an open-chain
bis(iminopyridine) ligand with a para-xylylene linker. This system is very flexible and can
easily modulate the metal-metal distance. Therefore, we anticipated that it should allow
a good fit for oxalate in the cavity.
This system design varies from many previously reported systems.17 Most systems
rely on more rigid ligand design thus allowing less variability in the cavity size. The
greatest difference between our system and those that have been previously investigated
is the lack of a fluorescence sensor. As described earlier, most sensors for oxalate rely
on fluorescence displacement assay to detect the amount of oxalate that binds to the
complex. These have the disadvantage of requiring expensive fluorescence sensors as

16

well as fluorometers. These drawbacks have prompted the design of a system that can
use colorimetric, or “naked-eye”, detection of oxalate.
2.2 Design and Synthesis of a Dinucleating Ligand (L1) and Di-Ni(II) and Di-Cu(II)
Complexes
The dinucleating ligand (L1) was synthesized following a procedure reported by
our group in a previous publication (Figure 2.1).25 The ligand contains a bulky 2,4,6triisopropylphenyl group on each pyridine to increase solubility and crystallinity, and to
protect the intrametallic cavity. The ligand was synthesized in two steps. The first step is
a Suzuki coupling reaction that adds the 2,4,6-triisopropylphenyl group to the 6’ position
of the pyridine (30% yield). The second step is a condensation of two equivalents of the
synthesized pyridine with one equivalent of the p-xylylenediamine to produce the ligand
in 98% yield.

Figure 2.1. The synthesis of dinucleating ligand L1.
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To synthesize metal complexes of L1, one equivalent of the ligand was dissolved
in tetrahydrofuran (THF) and then added dropwise to a stirred solution of two equivalents
of either nickel(II) bromide dimethoxyethane complex or copper(II) bromide (NiBr2(dme)
or CuBr2, Figure 2.2). Upon addition of the ligand to the metal complex solution an
immediate color change was noted, to pink for nickel(II) and green for copper. The
resulting solutions were filtered and volatiles were removed to yield complexes 1 and 2,
respectively. X-ray quality crystals were obtained by vapor diffusion of diethyl ether (Et2O)
into a saturated acetonitrile solution of 1 and 2. The X-ray structures are presented in
Figure 2.3 below. The X-ray structures of 1 and 2 reveal that the overall geometry of both
complexes is “anti”. The structures also demonstrate that each copper center in 2 has
incorporated an acetonitrile, and therefore exhibit penta-coordinate geometry, while the
nickel centers of 1 are tetrahedral. In Figure 2.6 the IR spectra can be seen for 1 - 4.

Figure 2.2. The synthesis of 1 and 2.
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Figure 2.3. X-ray crystal structures of 1 and 2, 50% probability ellipsoids. H atoms and
non-coordinated solvent molecules were omitted for clarity. Selected distances and
angles for 1: Ni --- Ni 11.309(1) Å, Ni – Br1 2.312(1) Å, Ni – Br2 2.318(1) Å, Ni – N1
2.006(3) Å, Ni – N2 1.980(3) Å, Br1 – Ni – Br2 135.0(1) °, N1 – Ni – N2 82.9(1) °. Selected
distances and angles for 2: Cu --- Cu 11.38(1) Å, Cu – Br1 2.474(1) Å, Cu – Br2 2.425(1)
Å, Cu – N1 1.970(3) Å, Cu – N2 2.227(3) Å, Cu – N3 1.952(3) Å, Br1 – Cu – Br2 151.1(1)
°, N1 – Cu – N2 79.2(1) °, N1 – Cu – N3 174.6 °.
2.3 Synthesis of the µ-Oxalate Complexes
With the synthesis of the prospective oxalate sensors completed we turned to
investigate their reactivity with oxalate. Complexes 1 and 2 were treated with one
equivalent of an oxalate source (A2[C2O4], A= NBu4, K, Na) in acetonitrile (see Figure 2.4
below). Upon addition of oxalate to 1, an immediate color change from red-pink to green
is observed. For 2, no significant color change was observed. After allowing the mixture
to stir for one hour, the resulting solutions were filtered (to remove ABr precipitate) and
the volatiles were removed. X-ray quality crystals were obtained by vapor diffusion of
Et2O into a saturated solution of acetonitrile to yield complexes 3 and 4 (see Figure 2.5
below). Most significantly, both structures demonstrate intramolecular coordination of
oxalate between the two metal centers of a dinuclear complex, which necessitates “syn”
geometry of the dinuclear complex. Interestingly, the X-ray crystal structure of 3 reveals
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that the nickel centers each have a different coordination environment: one nickel center
is penta-coordinate and the other is hexa-coordinate. Both copper centers of 4 exhibit
penta-coordinate coordination environment. The IR spectra of 3 and 4 can be seen in
Figure 2.6. Of note in the IR spectrum is the large peak around 1600 cm-1 corresponding
to the CO stretch in the oxalate. This peak closely resembles the corresponding peak
observed in the IR spectrum for sodium oxalate.

Figure 2.4. Synthesis of complexes 3 and 4.
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Figure 2.5. Structures of 3 and 4, 50% probability ellipsoids. H atoms and noncoordinated solvent molecules were omitted for clarity. Selected distances and angles for
3: Ni1 --- Ni2 5.36 Å, Ni1 – Br1 2.516(1) Å, Ni2 – Br2 2.425(1) Å, Ni1 – N1 2.062(2) Å,
Ni1 – N2 2.170(2) Å, Ni1 – N3 2.096(2) Å, Ni1 – O1 2.064(3) Å, Ni1 – O2 2.081(3) Å, Ni2
– N3 2.033(2) Å, Ni2 – N4 2.095(2) Å, Ni2 – O3 2.029(3) Å, Ni1 – O4 2.033(3) Å, O3 –
Ni2 – Br2 167.6(1) °, O4 – Ni2 – N2 163.6(1) °. Selected distances and angles for 4: Cu1
--- Cu2 5.20 Å, Cu1 – Br1 2.396(1) Å, Cu2 – Br2 2.362(1) Å, Cu1 – N1 2.240(2) Å, Cu1 –
N2 2.027(2) Å, Cu2 – N3 2.049(2) Å, Cu2 – N4 2.223(2) Å, Cu2 – O3 2.019(2) Å, Cu2 –
O4 1.991(2) Å, O2 – Cu2 – N2 171.6(1) °, O4 – Cu2 – N4 132.1(1) °.

Figure 2.6. IR Spectra of Complexes 1 – 4.
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2.4 Determination of the Binding Affinity of Oxalate to the Sensor
The quick and significant color change of red-pink 1 to green 3 following the
addition of oxalate prompted us to investigate the potential of 1 as a colorimetric sensor
for oxalate. First, we studied titration of compound 1 (to give 3) by oxalate using UV-vis
spectroscopy. UV-vis spectroscopy enables determination of the binding constant of
oxalate in 3. Figure 2.7 below shows the results of a titration of oxalate into a solution of
1, with the inset shows the original spectra of 1 and 3 separately. Compounds 1 and 3
give rise to the absorptions at 512 and 648 nm, respectively. As can be seen in Figure
2.7, as oxalate is added to the solution of, 1 the absorbance corresponding to 1 decreases
while that of 3 increases.

Figure 2.7. Spectrophotometric titration of 1 with (NBu4)2[C2O4] in CH3CN/THF. Inset:
Spectrum of the starting material (1, red line); spectrum of the product (3, green line).
The binding constant for 1:1 binding between the donor and acceptor is determined
using the equation below.33
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The terms in the equation are defined as follows:
ΔAobsd = observed change in absorption of metal complex after it is binds the ligand
(oxalate)

ε

∆HG

= change in molar absorptivity of the metal complex with and without ligand (in our

case, the difference between 1 and 3).
[M] = Concentration of the metal complex (1, mM)
[L] = Concentration of the ligand (oxalate, mM)
K = binding constant
The method of UV/vis titrations has been used to determine the binding constant,
K. In this method the concentration of the metal complex (1) was held constant (at 3.09
mM). Eight different samples were prepared with varying concentrations of the ligand
(oxalate). The concentrations of the ligand used are listed in Table 2.1. The values of
ΔAobsd are also shown in Table 2.1.
Table 2.1. The UV/Vis data used to plot binding isotherms for 1 and oxalate.
Concentration of metal complex was kept constant at 3.09 mM for all the samples.
Sample [Oxalate] (mM) -ΔAobsd
1
2
3
4
5
6
7
8

0
0.3097
0.6194
0.9291
1.2388
1.5485
1.8582
2.1679

0
0.037
0.055
0.105
0.123
0.163
0.182
0.191
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Generally, stronger absorption is observed for the product, resulting in the positive
ΔAobsd values. In the present case, stronger absorption was observed for the starting
material (1) versus the product (3). To account for this phenomenon, the equation was
modified by multiplying by (- 1) on both sides. The (ΔAobsd) values were plotted against
the concentration of the ligand to obtain series of data points. These points were fitted
into a non-linear curve using the method of non-linear least squares and by writing a
custom program using Igor software. This work was done in collaboration with Dr. Amar
Bheemaraju. The data analysis determined the binding constant K to be 5.2(5) x 102 M-1.
This value suggests that our complex does not bind oxalate as tightly as other
oxalate sensors, which may in fact be advantageous to the existing sensors. It is possible
that the reason behind this relatively weak binding of oxalate stems from the open-chain
highly flexible nature of our dinuclear complex. The majority of the oxalate sensors are
macrocycles (see also chapter 3); due to the very strong binding constants, other
complexes do not allow oxalate release and thus are not recyclable.17 We hypothesized
that because complex 1 has a lower binding affinity for oxalate we might be able to recycle
the sensor by removing oxalate after the initial binding (see 2.6).
2.5 The Competitive Binding of Oxalate Versus Other Physiological Ions
An efficient oxalate sensor should be selective for oxalate versus other
physiological ions.17 We tested the selectivity of our system for oxalate versus most
closely related ions, mono- and di-carboxylates: formate, acetate, succinate, malonate,
and glutarate. To test the selectivity of 1 for oxalate versus these ions, we developed a
novel method that relies on mass spectrometry. Complex 3 demonstrates a signature
peak at 1003.3 m/z, a “molecular ion” peak, in its ESI-MS. This peak corresponds to the
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loss of one bromide to create the [Ni2(L1)(C2O4)Br]+ ion (Figure 2.8 below). For each
“competitor ion”, two mass spectra were taken, one containing a mixture of 1 with the
“competitor ion”, and the other containing the mixture of 1 with the competitor ion and
equimolar amount of oxalate.

As can be seen in the left side of Figure 2.9, the

carboxylates indeed form complexes with 1. Then to this mixture of 1 and the competitor
one equivalent of oxalate was added and the mass spectrum was taken again. As can be
seen in the right side of Figure 2.9, oxalate is out-competes the “competitor” carboxylate
and 3 is the most concentrated peak in the spectra, demonstrating a significant selectivity
of 1 for oxalate. Yet, other signals (especially with relatively flexible glutarate) are also
detected, which demonstrates that the oxalate selectivity of 1 is not perfect.

Figure 2.8. Experimental and calculated ESI-MS spectrum of complex 3 in the 1000 1015 region, demonstrating the peak attributed to [3-Br-CH3CN]+.
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Figure 2.9. Competitive binding studies. Left: ESI mass spectra (in the range of m/z 10001100) of the reaction mixtures of complex 1 with formate, acetate, malonate, succinate,
and glutarate. Right: ESI mass spectra (in the range of m/z 1000 - 1100) of the
competition experiments involving addition of oxalate to the reaction mixtures of complex
1 with formate, acetate, malonate, succinate, and glutarate.
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2.6 Regeneration of the Sensor by Oxalate Extraction
As discussed in 2.4, all previously reported chemosensors demonstrated strong
affinity for oxalate and therefore inevitably were of single use, as oxalate could not be
extracted. However, since 1 was found to have relativity low binding affinity for oxalate,
we postulated that in our system oxalate can be extracted from the sensor and the sensor
can be recycled. To test this hypothesis, compound 3 was treated with excess calcium
bromide in THF (see Figure 2.10). Color change of green back to red-pink was observed,
signifying oxalate release. Recrystallization of the reaction products yielded 1 which cocrystallized with CaBr2•(THF)4 (see Figure 2.11).

Figure 2.10. Oxalate extraction from 3.
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Figure 2.11. X-ray structure of 1•CaBr2(THF)4 (50% probability ellipsoids). H atoms and
non-coordinated solvent molecules were omitted for clarity.
2.7 Summary and Conclusions
The first recyclable colorimetric chemosensor for the detection of oxalate was
synthesized. This recyclability is the result of the flexible nature of the chemosensor which
results in a lower binding affinity, however allowing at the same time facile oxalate
extraction and sensor regeneration. The sensor was also shown to be relatively selective
for oxalate versus other carboxylates of physiological importance. In order to show this
selectivity a novel analytical method was developed, that relies on mass spectrometry.
2.8 Experimental Details
Nickel(II) bromide dimethoxyethane complex (NiBr2(DME)), copper(II) bromide,
oxalic acid dihydrate, tetrabutylammonium methoxide solution, potassium oxalate
dihydrate, sodium oxalate, ammonium formate, ammonium acetate, succinic acid
disodium salt, malonic acid and glutatric acid were purchased from Aldrich, Strem or TCI
America and used as received. All solvents were purchased from Fisher scientific and
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were of HPLC grade. The solvents were purified using an MBraun solvent purification
system and stored over 3-Å molecular sieves. Compounds were routinely characterized
by 1H NMR spectroscopy, Evans’ method, X-ray crystallography, IR spectroscopy,
elemental analyses, and mass spectrometry (ESI). NMR spectra were recorded at the
Lumigen Instrument Center (Wayne State University) on a Varian Mercury 400 NMR
Spectrometer in CD3CN at room temperature. Chemical shifts and coupling constants (J)
were reported in parts per million (δ) and Hertz respectively. IR spectra of powdered
samples were recorded on a Shimadzu IR Affinity-1 FT-IR Spectrometer outfitted with a
MIRacle10 attenuated total reflectance accessory with a monolithic diamond crystal stage
and pressure clamp. Low resolution mass spectra were obtained at the Lumigen
Instrument Center utilizing a Waters Micromass ZQ mass spectrometer (direct injection,
with capillary at 3.573 (KV) and cone voltage of 20.000 (V)). Only selected peaks in the
mass spectra are reported below. UV-visible spectra were obtained on a Shimadzu UV1800 spectrometer. Elemental analyses were performed under ambient conditions by
Midwest Microlab LLC or Columbia Analytical Services, Inc.
Synthesis of 6-(2,4,6-triisopropylphenyl)-2-pyridinecarboxaldehyde. This compound was
prepared in a similar way to the previously reported 4-fluoro-2’,4’,6’-triisopropylbiphenyl3-carbaldehyde.12

Under

a

nitrogen

atmosphere,

6-bromo-2-

pyridinecarboxyaldehyde (1.60 g, 8.60 mmol), 2,4,6-triisopropylphenylboronic acid (3.20
g, 12.89 mmol), 2-dicyclohexylphosphino-2’,6’-dimethoxybiphenyl (SPhos) (0.60 g, 1.48
mmol), and K3PO4 (20 g, excess base) were added to a 250 ml Schlenk flask. The flask
was evacuated and refilled with nitrogen three times. Toluene (35 ml) and Pd(OAc)2 (0.38
g, 1.71 mmol) were added to the flask. The reaction mixture was heated to 110 oC for 48
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h. After that, the reaction mixture was cooled to room temperature and diethyl ether (50
ml) was added. The resulting reaction mixture was filtered through thin pad of silica gel,
and the resulting filtrate was concentrated in vacuo. The crude product was purified by
silica gel chromatography (5:95 ether:hexanes) to afford the product, 6-(2,4,6triisopropylphenyl)-2-pyridinecarboxaldehyde (0.80 g, 30 %) as a solid. 1H NMR (C6D6,
400 MHz) δ 10.16 (s, 1H), 7.63 (d, J = 7.2 Hz, 1H), 7.20 (s, 2H), 6.99 (d, J = 7.2 Hz, 1H),
6.96 (q, J = 7.6 Hz, 1H), 2.86 (m,1H), 2.55 (m, 2H), 1.27 (d, J = 6.8 Hz, 6H), 1.12 (t, J =
6.8 Hz, 12H); 13C NMR (C6D6, 75 MHz) δ 193.57, 161.57, 153.50, 149.98, 147.14, 136.89,
129.36, 128.73, 128.62, 128.14, 121.37, 119.47, 35.29. 31.31, 24.83, 24.71, 24.38;
HRMS (ESI) calcd for [C21H27NO+H]+ 310.2171, found 310.2181. Mp: 199 °C.
Synthesis of L1. A 20 mL methanol solution of 6-(2,4,6-triisopropylphenyl)-2pyridinecarboxaldehyde (39 mg, 0.12 mmol) was added to a 20 mL methanol solution of
p-xylylenediamine (85 mg, 0.06 mmol). The resulting solution was stirred and refluxed for
4h. The reaction mixture was cooled to room temperature. White powder was separated
from the solution by filtration, washed with cold methanol, and dried to obtain L1 (88 mg,
98 %) as a white solid. 1H NMR (CD2Cl2, 400 MHz) δ 8.48 (s, 2H), 8.03 (d, J = 8.0 Hz,
2H), 7.78 (t, J = 7.6 Hz, 2H), 7.37 (s, 4H), 7.28 (d, J = 7.6 Hz, 2H), 7.08 (s, 4H), 4.85 (s,
4H), 2.92 (m, 2H), 2.48 (m, 4H), 1.26 (d, J = 6.8 Hz, 12H), 1.07 (dd, J = 3.6 Hz, 2.8 Hz,
24H);
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C NMR (CD2Cl2, 75 MHz) δ 163.99, 160.18, 154.94, 149.69, 146.97, 138.72,

136.79, 136.73, 128.82, 126.69, 121.22, 119.08, 65.22, 35.07, 30.91, 30.27, 24.46, 24.28.
HRMS (ESI) calcd for [C50H62N4+H]+ 719.5053, found 719.5063. Mp: 255 °C.
Synthesis of Ni2(L1)Br4 (1) - To a 3 mL solution of NiBr2DME (17.2 mg, 0.056 mmol) in
THF a slurry of L1 (20.0 mg, 0.028 mmol) in 3 mL of THF was added. The mixture was
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allowed to stir for one hour. The resulting pink solution was filtered. The solvent of the
filtrate was removed in vacuo. X-ray quality pink crystals were obtained by vapor diffusion
of diethyl ether into a concentrated THF/CH3CN solution yielding 26.0 mg of Ni2(L1)Br4 (1,
82%). M.p. 215 °C (decomposition). ESI-MS Calcd for [C50H62N4Ni2Br3]+ (1 – Br) 1071.1,
found 1071.5. Anal. Calcd for C50H62N4Ni2Br4: C, 52.0; H, 5.4; N, 4.9. Found: C, 52.3; H,
5.3; N, 5.0. The structure was also confirmed by X-ray structure determination. 1H NMR
(CD2Cl2, 400 MHz) δ 1.3, 1.6, 2.9, 10.7, 16.0, 18.9, 45.5, 77.4 ppm. μeff (Evans, CD2Cl2,
298 K): 4.83 μB. IR (cm–1): 2956 (s), 1458 (s), 1369 (m), 1170 (m), 1050 (m), 880 (m).
Synthesis of Cu2(L1)Br4(CH3CN)2 (2) – To a 3 mL solution of CuBr2 (8.0 mg, 0.056 mmol)
in THF a slurry of L1 (20.0 mg, 0.278 mmol) in 3 mL of THF was added. Upon the addition,
the color changed to green-yellow. The mixture was allowed to stir for one hour. The
solvent was removed under vacuum. X-ray quality green crystals were obtained by
vapour diffusion of Et2O into a concentrated CH3CN solution yielding Cu2(L1)Br4(CH3CN)2
(2, 24.0 mg, 75%). M.p. = 90 °C (decomposition). Anal. Calcd. for C54H68Br4N6Cu2: C,
51.9; H, 5.5; N, 6.7 Found: C, 51.3; H, 5.4; N, 6.4. ESI-MS Calcd for [C50H62N4Cu2Br2]+
(1- 2Br) 1002.2, found. 1002.6. The structure was confirmed by X-ray structure
determination. μeff (Evans, CD2Cl2, 298 K): 2.16 μB. IR (cm–1): 2956 (s), 2360 (w), 1458
(s), 1369 (m), 1170 (m), 1050 (m), 880 (m).
Synthesis of (NBu4)2[C2O4] – This procedure is a modification of a previously reported
method.14 To a 20 mL solution of oxalic acid dihydrate (0.500 g, 3.976 mmol) 13.3 mL of
(NBu4)(OMe) (20% in MeOH) solution was added. The reaction was allowed to stir for 4
hours. The solvent was removed under vacuum. The resulting solid was dried under high
vacuum for 24 h yielding 2.22g (98%) of (NBu4)2[C2O4]. 1H NMR (CD3CN, 400 MHz) δ
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3.15 (t, J = 8.0 Hz, 16H), 1.59 (q, J = 6.4 Hz, 16H), 1.33 (q, J = 7.2 Hz, 16H), 0.93 (t, J =
6.8 Hz, 24H) ppm. 13C NMR (CD3CN, 75 MHz) δ 176.72, 59.20, 24.40, 20.34, 13.87 ppm.
Synthesis of Ni2(L1)(μ-C2O4)Br2(NCMe) (3) – To a 3 mL of solution of 1 (26.3 mg, 0.023
mmol) in THF a 2 mL solution of (NBu4)2[C2O4] (13.0 mg. 0.023 mmol) in CH3CN was
added, resulting in green solution. The mixture was allowed to stir for one hour, filtered,
and the volatiles were removed in vacuo. Green X-ray quality crystals were obtained by
slow diffusion of ether into CH3CN yielding 20 mg of Ni2(L1)(μ-C2O4)Br2(NCMe) (3, 78%).
M.p. = 207 °C (decomposition). ESI-MS Calcd for [C50H62N4Ni2C2O4Br]+ (3 – Br – CH3CN)
1001.3, found 1001.3. Anal. Calcd for C54H65N5Ni2Br2O4: C, 57.6; H, 5.8; N, 6.2. Found:
C, 56.6; H, 5.8; N, 6.0. The structure was also confirmed by X-ray structure determination.
IR (cm–1): 2956 (s), 1647 (s), 1607 (s), 1458 (s), 1369 (m), 1310 (m), 1170 (m), 1050 (m),
880 (m).
Synthesis of Ni2(L1)(μ-C2O4)Br2(CH3CN) (3) using NaC2O4 or KC2O4 – To a 3 mL of
solution of 1 (26.0 mg, 0.028 mmol) in THF K2C2O42H2O (5.0 mg, 0.028 mmol) in 1 mL
of MeOH was added. Upon the addition, the color changed to dark green. The mixture
was allowed to stir for 1 h then filtered. The resulting green solution was concentrated
under vacuum. Green X-ray quality crystals were obtained by slow diffusion of ether into
CH3CN yielding Ni2(L1)(μ-C2O4)Br2(CH3CN) (18 mg, 72%) as green crystals. The nature
of the product was confirmed by the unit cell determination (identical to the unit cell of 3).
The compound 3 can be obtained in a similar fashion using the solution of NaC2O4 (3.7
mg. 0.0278 mmol) in a 1:1 mixture of MeOH:H2O.
Synthesis of Cu2(L1)(C2O4)Br2 (4) – To a 3 mL of solution of 2 (66 mg, 0.0556 mmol) in
CH3CN a 2 mL solution of (NBu4)2[C2O4] (32 mg. 0.056 mmol) in CH3CN was added.
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Upon the addition, the color changed to dark green. The mixture was allowed to stir for 1
h then filtered. The resulting green solution was concentrated under vacuum. Green Xray quality crystals were obtained by slow diffusion of ether into CH3CN yielding
Cu2(L1)(C2O4)Br2 (4, 50 mg, 83%). M.p. = 152 °C (decomposition). Anal. Calcd. for
C52H64Br2N4O4Cu2:C, 57.1 H, 5.7 N, 5.1 Found: C, 57.1 H, 5.7 N, 5.2. The structure was
also confirmed by X-ray structure determination. IR (cm–1): 2956 (s), 1647 (s), 1607 (s),
1458 (s), 1369 (m), 1310 (m), 1170 (m), 1050 (m), 880 (m).
Oxalate extraction from Ni2(L1)(μ-C2O4)Br2(CH3CN) (3) to form Ni2(L1)Br4•CaBr2THF4
(1•CaBr2THF4) – To a green 3 mL of solution of 3 (12 mg, 0.011 mmol) in CH3CN a
colourless 2 mL solution of CaBr2 in CH3CN (4 mg. 0.02 mmol) was added. The reaction
color immediately turned red-pink, and white precipitate formed. The mixture was allowed
to stir for 1 h then filtered. The resulting red-pink solution was concentrated under
vacuum. Pink x-ray quality crystals were obtained by slow diffusion of ether into THF
solution yielding Ni2(L1)Br4•CaBr2THF4 (1•CaBr2THF4, 14 mg, ca. 90%). The nature of the
product was established by the X-ray structure determination.
General procedure for obtaining the ESI-MS of the products of the reaction of 1 with
mono- and di-carboxylates – To a solution of L1 (20 mg, 0.278 mmol) and 2 equiv.
NiBr2DME (17 mg, 0.556 mmol) in THF a mixture of 1 equiv of the corresponding monoor dicarboxylate ion (formate, acetate, succinate, malonate, and gluratate) in MeOH was
added and shaken for 2 min. An aliquot of the resulting solution was then injected into the
ESI-MS for analysis.
General procedure for obtaining the electrospray mass spectra of the products of the
reaction of 1 with the mixtures of mono- and dicarboxylates with oxalate – To a solution
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of L1 (20 mg, 0.278 mmol), 2 equiv NiBr2DME (17 mg, 0.556 mmol) in THF and 1 equiv
of the competitor ion (formate, acetate, succinate, malonate, and gluratate) in MeOH a
mixture of 1 equiv of (NBu4)2[C2O4] (16 mg, 0.278 mmol) was added and shaken for 2
min. An aliquot of the resulting solution was then injected into the ESI-MS for analysis.
X-ray crystallographic details
Structures of compounds 1, 2, 3, 4, and 1•CaBr2(THF)4 were confirmed by X-ray
structure determination. The crystals were mounted on a Bruker APEXII/Kappa three
circle goniometer platform diffractometer equipped with an APEX-2 detector. A graphic
monochromator was employed for wavelength selection of the Mo Kα radiation (λ =
0.71073 Å). The data were processed and refined using the APEX2 software. Structures
were solved by direct methods in SHELXS and refined by standard difference Fourier
techniques in the SHELXTL program suite (6.10 v., Sheldrick G. M., and Siemens
Industrial Automation, 2000). Hydrogen atoms were placed in calculated positions using
the standard riding model and refined isotropically; all other atoms were refined
anisotropically. Some of the para-iPr groups displayed large wagging motion which in
selected cases (1) was successfully modelled as two different conformations. In contrast,
we had only limited success in modelling the disorder of the para-iPr groups in the
structures of 2 and 3. Even though these structures were collected at 100K the thermal
parameters for some of these groups were very high. The conclusion is that these groups
are not well defined and thus some were refined isotropically. The isotropic refinement of
these atoms does not significantly alter the R-factor, and does not alter the conclusions
of this worl in any way. Structures of 3 and 4 contained one molecule of ether solvent,
and one molecule of acetonitrile in the asymmetric unit. Structure of 1•CaBr2(THF)4
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contained one molecule of ether solvent in the asymmetric unit. The acetonitrile ligands
in the structures of 2 and 3 were disordered over two positions. In addition, the structure
of 2 contained acetonitrile solvent disordered over two positions in the asymmetric unit.
Detailed crystal and structure refinement data is given in Table 2.2 below.
Table 2.2. Crystal and structure refinement data 1 - 4.
1

2

3

4

1•CaBr2(THF)4

formula

C25H26Br2N2
Ni

C29H35Br2CuN5

C57H68N7Br2
Ni2O4

C108H134Br4
N8Cu4O9

C37H57Br3N2O3
CaNi

Fw, g/mol

573.01

676.98

1208.42

2262.03

916.36

temperature

100(2) K

100(2) K

100(2) K

100(2) K

100(2) K

cryst syst

monoclinic

triclinic

triclinic

triclinic

triclinic

space group

P21/c

P-1

P-1

P-1

P-1

colour

pink

green

green

green

red

Z

4

2

2

2

2

a, Å

15.3126(2)

9.1051(5)

11.712(2)

12.8703(6)

8.8371(5)

b, Å

9.0515(1)

9.2898(5)

15.739(2))

17.2304(8)

10.2867(5)

c, Å

18.877(2)

18.974(1)

17.852(2)

25.5224(1)

23.517(1)

α, deg

90.00

98.136(3)

112.722(6)

108.311(2)

97.730(3)

β, deg

106.357(5)

99.496(3)

93.496(6)

102.265(2)

93.580(3)

γ, deg

90.00

103.440(3)

95.234(6)

91.872(2)

110.826(2)

V, A3

2510.5(5)

1512.24(14)

3006.1(7)

5220.4(4)

1965.88(2)

dcalcd, g/cm3

1.516

1.487

1.335

1.439

1.548

μ, mm-1

3.969

3.390

2.005

2.394

3.709

2θ, deg

50.48

50.48

50.48

50.48

50.48

R1a (all data)

0.0576

0.0615

0.0711

0.0528

0.0775

wR2b
data)

0.1077

0.1140

0.1418

0.0712

0.1221

0.0404

0.0483

0.0480

0.0329

0.0494

(all

R1a [(I>2σ)]
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wR2b [(I>2σ)]

0.0996

0.1090

0.1247

0.0663

0.1105

GOF (F2)

1.093

1.371

1.061

1.051

1.017

R1 = S||Fo – |Fc||/S|Fo|. b wR2 = (S(w(Fo2 – Fc2)2)/S(w(Fo2)2))1/2. c GOF = (S w(Fo2 – Fc2)2/(n – p))1/2
where n is the number of data and p is the number of parameters refined.
a
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CHAPTER 3 OXALATE-TEMPLATED SYNTHESIS OF DI-ZINC MACROCYCLES
Portions of this chapter we reprinted or adopted from: Beattie, J. W.; SantaLucia, D. J.;
White, D. S.; Groysman, S. Inorg. Chim. Acta. 2016, doi:10.1016/j.ica.2016.02.063
(Special Issue: New Generation).26 All rights to this work are retained by the authors and
any reuse requires the permission of the authors.
3.1 Introduction
As described in chapter 2, compound 1 has a relatively weak binding constant for
oxalate, which allows it to serve as a recyclable chemosensor for oxalate. However, as
the mass spectra in Figure 2.9 demonstrate, it is not a perfect sensor, demonstrating
somewhat low selectivity, specifically towards the mixture of oxalate with glutarate. We
decided next to design a system that would bind oxalate more tightly and would be more
selective towards oxalate. Toward this goal, we designed a new macrocycling system
containing two chelating bis(imino)pyridine units bridged by either meta(m)- or para(p)xylelene linkers – these linkers proved satisfactory for oxalate coordination in the openchain sensor (See Figure 3.1 below). As similar linkers (to compound 1) were used, we
hoped that the new systems may still enable reversibility in oxalate coordination, while
improving selectivity.
3.2 Synthesis and Crystal Structure Determination of Di-Zn Macrocyclic Complexes
Our first attempt to synthesize the macrocyclic ligand followed similar approach as
in the synthesis of the L1. However, straightforward condensation of either 2,6diacetylpyridine

or

2,6-pyridinedicarboxaldehyde

with

m-xylelenediamine

or

p-

xylelenediamine did not yield the desired product. We were unable to determine the
nature of the reaction products as they were not soluble in common organic solvents. Due
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to their lack of solubility, we hypothesized that instead of the small macrocycles, longchain polymers were formed. Therefore, we turned to a template synthesis.28 We note
that Burrows and coworkers have synthesized a di-copper complex of a similar ligand,
used imidazole as a template for the formation of their macrocycle.28 Since we are
interested in these complexes as possible oxalate sensors we determined that using
oxalate as a template would provide us valuable information about its ability to fit in the
intramolecular cavity. We also chose to use a diamagnetic zinc(II) metal as the initial
metal of choice. The choice of a diamagnetic metal enables the use of the NMR “handle”
that is of great importance in the exploratory synthesis, as it allows rapidly and accurately
analyze the products. We also note that zinc is an appropriate metal to be used in an
oxalate sensor as it possesses comparable oxophility to nickel(II), and zinc-based oxalate
sensors have been previously investigated.29
Synthesis of the macrocyclic compounds 5-7 is outlined in Figure 3.1. All reactions
were carried out as one-pot template-assisted condensations. Specifically, a stirring
solution

containing

two

equivalents

of

zinc

triflate

and

one

equivalent

of

tetrabutylammonium oxalate in methanol was treated with either the 2,6-diacetylpyridine
or 2,6-pyridinedicarboxaldhyde, followed by solution of the m-xylelenediamine or pxylelenediamine. Using this method with all possible permutations, we were able to isolate
three of the four possible products (5-7). The reaction of the 2,6-diacetylpyridine with pxylelenediamine yielded no soluble product that could be identified by NMR spectroscopy.
We note that the templated formation of the di-zinc complexes 5-7 is selective for oxalate.
Thus, we attempted similar reactions with zinc triflate, 2,6-diacetylpyridine, and mxylylenediamine, in the presence of various mono- and dicarboxylate salts, (formate,
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acetate, succinate and malonate). None of these reactions led to macrocycle formation,
as indicated by 1H NMR and mass spectrometry.
The complexes 5-7 showed low solubility except in the most polar organic solvents
DMF and DMSO. Using different solvent combinations, we were able to isolate X-ray
crystal structures of 6 and 7 as DMF adducts; the structure of 6 as an H2O-adduct was
also isolated and characterized. (Figures 3.2 – 3.4). While there are many examples of
oxalate bridging between zinc atoms, these represent the first examples of oxalate
bridging two zinc centers intramolecularly.30 A noteworthy difference between the two
structures involves the tighter and more symmetrical packing of L3 versus L2: the
asymmetric unit in the structure of 3-DMF2 constitutes only half of the bimetallic
complex/L3 ligand versus the whole complex in the case of L2 (Figure 3.5). Hoping to
improve solubility, we also synthesized complex 8 which features a tBu in the 3’ position
of the pyridine ring (Figure 3.1). However, introduction of a tBu group had little effect on
the overall solubility of the complex.
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Figure 3.1. Synthesis of complexes 5 – 8.

Figure 3.2. X-ray structure (50% probability ellipsoids) of 6-DMF2. H-atoms and noncoordinating trfilates omitted for clarity.
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Figure 3.3. X-ray structure (50% probability ellipsoids) of 6-OH2. H-atoms and noncoordinating trfilates omitted for clarity.

Figure 3.4. X-ray structure (50% probability ellipsoids) of 7-DMF2. H-atoms and noncoordinating trfilates omitted for clarity.
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Figure 3.5. Comparison of the top views of the structures of 7-DMF2 and 6-DMF2
illustrating more symmetrical coordination of L3.
Burrows and coworkers have reported a di-Cu(II) structure with a with L3 with
bridging imidazolate.28 The differences between the Zn2-oxalate bridged structure and
Cu2-imidazolate bridged structure are noteworthy. The zinc-oxalate structure is
centrosymmetric, which implies “anti-parallel” arrangement of the bridging m-xylylenes
(Figure 3.6, right). In contrast, the copper-imidazole structure is non-centrosymmetric
(Figure 3.6, left). Furthermore, it features two distinct copper(II) centers, one binding
triflate, and the other coordinating water. Due to the structural constraints imposed by
bridging imidazolate, two di(imino)pyridine chelates are bent toward each other (angle
between two [NNN] planes is 120 º). This, in turn, leads to the “syn-parallel” arrangement
of the bridging xylylene units. Oxalate coordination, in contrast, imposes anti-parallel
geometry of the m-xylylene bridges which in turn leads to the angle of nearly 180°
between the [NNN] planes. In both cases, the two xylylene linkers and the bridging ligand,
imidazolate or oxalate, form a “triple decker”. However, while the “syn-parallel”
arrangement in the Burrows’ complex leads to the imidazolate being sandwiched between
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xylylenes, the anti-parallel arrangement in the Zn-oxalate systems leads to the ladder-like
triple decker.

Figure 3.6. Schematic drawing of the cores of the complexes with imidazolate and
oxalate linkers demonstrating different conformations of the macrocyclic ligand as
function of their template.
3.3 Characterization of Di-zinc Complexes
We characterized all synthesized compounds by mass spectrometry, 1H NMR, 13C
NMR, 19F NMR spectroscopies, cyclic voltammetry, and elemental analysis. As the data
is similar for all complexes, only the data for 7 will be presented and discussed. Figure
3.7 shows the full 1H NMR spectrum of 7, and a section of the

13

C NMR spectrum of 7

demonstrating the resonance attributed to the oxalate carbon [C2O4]. The 1H NMR
spectrum indicates the overall C2V symmetry of the complex as there is only one
resonance for the methylene protons as well as the ketimine protons. The

13

C NMR

demonstrates the resonance for oxalate carbon at 166.8 ppm. The ESI-MS spectrum of
7 has two large peaks representing loss of one or two triflates, respectively (Figure 3.8).
The insets of Figure 3.8 show the enlarged areas around the peaks m/z = 372 and m/z
= 891 regions which represent {[(Zn2(L3)(C2O4)](O3SCF3)}1+ {7-O3SCF3} and the dipositive ion {[(Zn2(L3)(C2O4)])}2+ {7-(O3SCF3)2} respectively.
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Figure 3.7. 1H NMR spectrum of compound 7 in CD3CN. Insert zoom in of
spectrum of compound 7 showing oxalate carbon at 166.78 ppm.

13

C NMR
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Figure 3.8. ESI-MS spectrum of compound 7; insets demonstrate peaks attributed to
{[(Zn2(L3)(C2O4)](O3SCF3)}1+ (at m/z 891.07) and [(Zn2(L3)(C2O4)]2+ (at m/z 371.06).
Zinc(II)

is

generally

considered

a

redox-inactive

metal.

However,

bis(imino)pyridine chelate is redox non-innocent and has been shown to undergo several
redox events when attached to redox-inactive metal.31 Having synthesized the system
with two redox-inactive metals bridging two redox-active chelates via another possibly
redox-active fragment, oxalale,16 we decided to interrogate the overall redox properties
of the system, using cyclic voltammetry. The cyclic voltammogram (CV) of 7 is given in
Figure 3.9. Within the investigated window of +1 V to -2.8 V (in CH3CN, vs. Fc/Fc+), three
reduction events were observed. The first two reduction events (up to -2.3 V) are quasireversible and are assigned to the reduction of the ligand. The third irreversible wave (at
- 2.6 V), that also likely originates at the bis(imino)pyridine, leads to the overall irreversible
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behavior. We note the lack of electrochemical features consistent with oxalate oxidation
within the attempted scan range.

Figure 3.9. Top: Cyclic voltammetry of complex 7 in 1 ̶ -2.8 V region. Bottom: cyclic
voltammetry of complex 3 in -0.7 ̶ -2.3 V region. Conditions: DMSO, 0.1 M (PF6)(NBu4)
supporting electrolyte, 100 mV/s scan rate.
3.4 Attempts at Oxalate Extraction
Next, we turned to study oxalate extraction. Towards this goal, several different
approaches were evaluated. The first approach involved the reaction of the oxalate
complex with excess CaBr2 (to precipitate insoluble CaC2O4) as this method was
successful in our previous study. Treatment of the representative complex 7 with 2-20
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equivalents of CaBr2 resulted in complex product mixtures, according to 1H NMR
spectroscopy. Recrystallization of the products from the reaction of complex 7 with four
equivalents of CaBr2 via vapor diffusion of Et2O into DMSO enabled isolation of complex
9, albeit in low yield (Figure 3.10). Complex 9 (Figure 3.11) represents “partial” extraction
of oxalate where one Zn center is bound to two oxygen atoms of oxalate and the other
Zn center is bound by only one oxygen atom (Figure 3.11). The η1/η2 binding mode of
oxalate is not common however it is precedented.17 In addition, zinc(II) centers are ligated
by bromide ligands. Thus, CaBr2 serves in this reaction primarily to exchange counterions
(triflate for bromide), and not to remove oxalate. Excess CaBr2 does not lead to oxalate
extraction. This experiment clearly indicates that oxalate is bound stronger in macrocyclic
7 than in the open-chain 3.

Figure 3.10. Oxalate extraction studies carried out on 7.
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Figure 3.11. X-ray structure (50% probability ellipsoids) of 9. H-atoms are omitted for
clarity.
Next, we tested the reactivity of 7 with acetic acid (to protonate oxalate), EDTA
(metals extraction), and Me3SiCl (to remove oxalate by silylation). All the experiments
above failed to affect oxalate coordination in 7. Therefore, we tried protonation with 1.0
M HCl in H2O. We were not able to isolate macrocycle-containing product from this
reaction, likely due to the ensuing hydrolysis. Thus, an experiment was designed where
the extraction of oxalate could be monitored by mass spectrometry. In this experiment, a
solution of 7 was injected into the mass spectrometer and the spectrum recorded after
which the same solution was treated with 1.0 M HCl and then injected again into the mass
spectrometer and spectra recorded. Mass spectrommetry revealed a peak corresponding
to [(Zn2(L3)(Cl3)(OH2)]+ (Figure 3.12), which corresponds to the full removal of oxalate
from the cavity. However, subsequent attempts to isolate [(Zn2(L3)(Cl3)(OH2)]+ were
unsuccessful.
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Figure 3.12. ESI-MS spectrum of the reaction mixture of compound 7 with HCl (1.0 M in
H2O) that demonstrates formation of [(Zn2(L)(Cl)3(OH2)]+ species (at m/z 777.07), along
the starting materials at m/z 891.07 and m/z 391.07. Inset top: high-resolution mass
spectrum attributed to [(Zn2(L)(Cl)3(OH2)]+ species. Inset bottom: predicted mass
spectrum of [(Zn2(L)(Cl)3(OH2)]+.
3.5 Summary and Conclusion
In summary, we demonstrated that macrocyclic complexes can be assembled
using oxalate template. These complexes bind oxalate significantly stronger that their
open-chain analogues. We were able to demonstrate oxalate extraction by ESI-MS, using
a relatively harsh reagent, hydrochloric acid. While oxalate extraction was achieved, we
were not able to isolate the oxalate-free sensor, likely due to the hydrolysis of the imino
functionality. Thus, this system does not allow “reversibility” previously observed for the
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open-chain system, and cannot function as an oxalate sensor. Possible improvement of
the system involves reduction of the imino functionality to amine. Replacement of the
imino by amino will serve dual purpose: (i) the ligand will become more robust and less
sensitive to hydrolysis, while (ii) the sensor will acquire a significant degree of flexibility to
enable reversible binding of the substrate.
3.6 Experimental Details
All reactions were executed under ambient conditions except for the reactions
involving trimethylsylil chloride, which were done under nitrogen atmosphere. pXylylenediamine, m-xylylenediamine, 2,6-diacetylpyridine, 2,6-pyridinecarboxaldehyde,
zinc triflate, oxalic acid, and tetrabutylammonium methoxide were purchased from
Aldrich, Strem or TCI America and used as received. [C2O4](NBu4)2 was synthesized as
previously described.[7d] All solvents were purchased from Fisher Scientific and were of
HPLC grade. The solvents were purified using an MBRAUN solvent purification system
and stored over 3-Å molecular sieves. Compounds were routinely characterized by 1H,
13

C {H} NMR (13C NMR thereafter) and

19

F NMR, X-ray crystallography, and elemental

analyses. Selected compounds were characterized by mass spectrometry (ESI). NMR
spectra for all the compounds were recorded at the Lumigen Instrument Center (Wayne
State University) on a Varian Mercury 400 NMR Spectrometer in CD3CN, (CD3)2SO, and
CD3OD at room temperature. Chemical shifts and coupling constants (J) are reported in
parts per million (δ) and Hertz respectively. Low resolution mass spectra were obtained
at the Lumigen Instrument Center utilizing a Waters Micromass ZQ mass spectrometer
(direct injection, with the capillary at 3.573 (KV) and a cone voltage of 20.000 (V)). Only
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selected peaks in the mass spectra are reported below. Elemental analyses were
performed by Midwest Microlab LLC.
Synthesis of [(Zn2(L2)(C2O4)](O3SCF3)2 (5) – To a 20 mL solution of zinc triflate (278 mg,
0.765 mmol) in MeOH a 20 mL solution of [C2O4](NBu4)2 (218 mg, 0.383 mmol) in MeOH
was added and allowed to stir for 5 min at which point a 20 mL solution of 2,6pyridinedicarboxalydehyde (112 mg, 0.765 mmol) was added. The resulting solution was
stirred for 5 min, and p-xylylenediamine was added (104 mg, 0.765 mmol). The resulting
solution was allowed to stir for 12 h yielding a cloudy solution. The solvent was removed
under reduced pressure to form a white solid. This solid was then washed with 200 mL of
THF. The resulting slurry was filtered and a white solid collected as pure
[(Zn2(L2)(C2O4)](O3SCF3)2 (0.299 g, 79%). 1H NMR (CD3CN, 400 MHz) δ 8.91 (s, 4H),
8.44 (t, J = 8.0 Hz, 2H), 8.11 (d, J = 8.0 Hz, 4H), 7.13 (s, 8H) 4.90 (s, 8H) ppm. 13C NMR
(CD3CN, 75 MHz) δ 160.20, 147.54, 145.33, 136.02, 130.74, 130.28, 63.60 ppm.
NMR (CD3CN, 400 MHz) δ -79.36 ppm.

19

F

HRMS (ESI) Cald for [C32H24N6O4Zn2]2+

343.0299, found 343.0100; Calcd for [C33H26F3N6O7SZn2]+ 835.0118, found 835.0150.
Anal. Calcd for C34H26F6N6O10S2Zn2: C, 41.35; H, 2.65; N, 8.51; Found C, 41.39; H. 2.92;
N, 8.28.
Synthesis of [(Zn2(L3)(C2O4)](O3SCF3)2 (6) – To a 20 mL solution of zinc triflate (278 mg,
0.765 mmol) in MeOH a 20 mL solution of [C2O4](NBu4)2 (218 mg, 0.383 mmol) in MeOH
was added and allowed to stir for 5 min at which point a 20 mL solution of 2,6pyridinedicarboxalydehyde (112 mg, 0.765 mmol) was added. The resulting solution was
stirred for 5 min at which point m-xylylenediamine was added (0.110 mL, 0.765 mmol).
The resulting solution was allowed to stir for 12 h yielding a cloudy solution. The solvent
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was removed under reduced pressure resulting in a white solid. This solid was then
washed with 200 mL of THF. The resulting slurry was filtered and a white solid (0.325 g,
86%) collected as pure [(Zn2(L3)(C2O4)](O3SCF3)2. 1H NMR (CD3CN, 400 MHz) δ 8.68 (s,
4H) 8.41 (t, J = 7.6 Hz, 2H), 8.077 (d, J = 7.2 Hz, 4H), 7.10 (s, 8H), 4.87 (s, 8H) ppm.

13

C

NMR (CD3CN, 75 MHz) δ 168.98, 160.29, 146.85, 145.18, 136.64, 130.87, 130.41,
130.14, 130.00, 62.62 ppm.
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F NMR (CD3CN, 400 MHz) δ -79.35 ppm. HRMS (ESI)

Calcd for [C32H24N6O4Zn2]2+ 343.0299, found 343.0222; Calcd for [C33H26F3N6O7SZn2]+
835.0118, found 835.0148 Anal. Calcd for C34H26F6N6O10S2Zn2 C, 41.35; H, 2.65; N, 8.51;
Found C, 41.09; H. 3.17; N, 8.27.
Synthesis of [(Zn2(L3)(C2O4)](O3SCF3)2 (7) – To a 20 mL solution of zinc triflate (278 mg,
0.765 mmol) in MeOH a 20 mL solution of [C2O4](NBu4)2 (218 mg, 0.383 mmol) in MeOH
was added and allowed to stir for 5 min at which point a 20 mL solution of 2,6diacetylpyridine (125 mg, 0.765 mmol) was added. The resulting solution was stirred for
5 min at which point m-xylylenediamine was added (0.110 mL, 0.765 mmol). The resulting
yellow solution was allowed to stir for 12 h yielding an orange solution. The solvent was
removed under reduced pressure. The resulting orange solid was then dissolved in 10
mL of DMSO, and 100 mL of THF was then added dropwise to the DMSO solution of
[(Zn2(L)(C2O4)](O3SCF3)2 to precipitate an orange solid. The solid was collected yielding
[(Zn2(L)(C2O4)](O3SCF3)2 (0.290 g , 73%). X-ray quality crystals were obtained by vapor
diffusion of ether into DMF. 1H NMR (CD3CN, 400 MHz) δ 8.51, (t, J = 7.2 Hz, 2H), 8.39
(d, J =7.6 Hz, 4H), 7.26 (t, J = 8.8 Hz, 2H) 7.04 (m, 6H), 4.85 (s, 8H), 2.74 (s, 12H) ppm.
13

C NMR (CD3CN-d3, 75 MHz) δ 166.79, 164.73, 147.14, 143.57, 135.81, 129.76, 128.83,

127.76, 126.28, 54.80, 15.20. 19F NMR (CD3CN, 400 MHz) δ -77.717 ppm. HRMS (ESI)
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Calcd for [C36H34N6O4Zn2]2+ 371.0612, found 371.0591; Calcd for [C38H34N6O7F3SZn2]+
891.0734, found 891.0781. Anal. Calcd for C38H38F6N6O10S2Zn2•3H2O C, 40.26; H, 3.91;
N, 7.41; Found C, 40.02; H, 3.90; N, 7.21.
Attempt to synthesize di-zinc complex with p-xylylendiamine and 2,6-ediacetylpyridine To a 20 mL solution of zinc triflate (278 mg, 0.765 mmol) in MeOH a 20 mL
solution of [C2O4](NBu4)2 (218 mg, 0.383 mmol) in MeOH was added and allowed
to stir for 5 min at which point a 20 mL solution of 2,6-diacetylpyridine
(125 mg, 0.765 mmol) was added. The resulting solution was stirred for 5 min
at which point p-xylylenediamine was added (104 mg, 0.765 mmol). The
resulting yellow solution was allowed to stir for 12 h yielding a yellow slurry. The solvent
was then removed. The resulting solid was insoluble in all conventional organic solvents
(i. e. THF, CH3CN, DMF, DMSO, MeOH).
Synthesis of [(Zn2(L3)(C2O4)](O3SCF3)2 (8) – To a 20 mL solution of zinc triflate (332 mg,
0.912 mmol) in MeOH a 20 mL solution of [C2O4](NBu4)2 (261 mg, 0.456 mmol) in MeOH
was added and allowed to stir for 5 min at which point a 20 mL solution of 3-tert-butyl2,6-diacetylpyridine (200 mg, 0.912 mmol) was added. The resulting solution was stirred
for 5 min at which point m-xylylenediamine was added (0.121 mL, 0.912 mmol). The
resulting yellow solution was allowed to stir for 12 h yielding an orange solution. The
solvent was removed under reduced pressure. The resulting orange solid was then
washed with 100 mL of THF. The solid was then collected by filtration yielding pure
[(Zn2(L3)(C2O4)](O3SCF3)2 (1.01 g, 96%). 1H NMR (CD3OD, 400 MHz) δ 8.39 (s, 4H), 7.32
(s, 2H); 7.26 (d, J = 7.2 Hz, 4H), 7.02 (s, 2H), 3.85 (s, 8H), 2.80 (s, 12H), 1.52 (s, 18H)
ppm.

13

C NMR (CD3OD, 75 MHz) δ 167.39, 149.44, 137.62, 131.02, 142.85, 124.71,
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123.95, 120.40, 69.03, 56.69, 30.83, 26.65 ppm. 19F NMR (CD3CN, 400 MHz) δ -79.919
ppm. HRMS (ESI) Calcd for [C44H48N6O4Zn2]2+ 427.1238, found 427.1094; Calcd for
[C45H50N6O7F3SZn2]+ 1003.1996, found 1003.2043.
Attempt to synthesize [(Zn2(L3)](O3SCF3)4 in the absence of oxalate - To a 20 mL solution
of

zinc

triflate

(278

mg,

0.765

mmol)

in

MeOH

was

added

a 10 mL solution of 2,6-diacetylpyridine (125 mg, 0.765 mmol) in MeOH. The
resulting solution stirred for 5 min before the addtion of m-xylylenediamine
(0.110 mL, 0.765, mmol). The mixture was allowed to stir for 16 h. The
solvent was then removed under reduced pressure resulting in an orange wax.
1

H NMR of the product showed no peaks corresponding to the desired product.

Attempt

at

the

synthesis

of

di-Zn

bridged

macrocycles

with

other

(formate/acetate/malonate/succinate) templates – To a 20 mL solution of zinc triflate (278
mg,

0.765

mmol)

in

MeOH

a

15

mL

solution

of

HCO2K/CH3CO2K/K2CO2CH2CO2/C4H6O4Na2 (32.2/38.0/68.3/62.0 mg, 0.383 mmol) in
MeOH was added and allowed to stir for 5 min at which point a 20 mL solution of 2,6diacetylpyridine (125 mg, 0.765 mmol) was added. The resulting solution was stirred for
5 min at which point m-xylylenediamine was added (0.110 mL, 0.765 mmol). The resulting
yellow solution was allowed to stir for 24 h yielding an orange heterogeneous mixture.
The resulting mixture was then filtered to collect an orange solid, which was only sparingly
soluble in DMSO or DMF.

A 1H NMR spectrum collected in DMSO-d6 shows no

resonances within the 1-12 ppm window. No peaks for any expected products were
observed by ESI-MS.
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Synthesis of [(Zn2(L3)(C2O4)Br2] (9) - A 10 mL solution of CaBr2 (370 mg, 1.86 mmol) in
DMSO was added to a stirring 30 mL solution of [(Zn2(L3)(C2O4)](O3SCF3)2 (compound
3, 485 mg, 0.465 mmol) in DMSO. The resulting orange solution was allowed to stir for
24 h. To the solution was added 200 mL of THF to precipitate an orange solid that was
then collected. X-ray quality crystals (67 mg obtained, 16% yield) were obtained by vapor
diffusion of ether into a concentrated DMSO solution. 1H NMR (DMSO-d6) 8.61 (t, J = 6.8
Hz, 2H), 8.56 (d, J = 6.8 Hz, 4H); 7.22 (t, J = 7.6 Hz, 2H); 6.70 (d, J = 7.6 Hz, 4H); 6.92
(s, 2H); 4.81 (s, 8H), 2.77 (s, 12H) ppm. HRMS (ESI) Calcd for [C36H34BrN6O4Zn2]+,
821.0408; Found, 821.0231.
The reaction of [(Zn2(L3)(C2O4)](O3SCF3)2 with acetic acid – To a stirring solution of
[(Zn2(L3)(C2O4)](O3SCF3)2 (50.0 mg, 0.479 mmol) in CH3CN was added 0.01 mL of
concentrated acetic acid. The resulting solution was allowed to stir for 24 h. The 1H NMR
spectrum showed no that no reaction had occurred.
The reaction of [(Zn2(L3)(C2O4)](O3SCF3)2 with HCl - To a stirring solution of
[(Zn2(L)(C2O4)](O3SCF3)2 (50.0 mg, 0.479 mmol) in CH3CN was added approximately 4
equivalents of 1.00 M HCl in CH3CN. The 1H NMR spectrum demonstrated formation of
a mixture of products. An aliquot of the resulting solution was then injected into the mass
spectrometer, to show formation of “[(Zn2(L3)(Cl)3(OH2)](O3SCF3)” (compound 9)
observed as [(Zn2(L3)(Cl)3(OH2)]+. ESI MS Calcd for [C34H36N6OZn2Cl3]+, 777.0599.
Found, 777.0700.
X-ray crystallographic details
The structures of 6-DMF2, 6-OH2, 7-DMF2, and 8 were determined by X-ray
analysis. The crystals were mounted on a Bruker APEXII/Kappa three circle goniometer
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platform diffractometer equipped with an APEX-2 detector. A graphic monochromator
was employed for wavelength selection of the Mo Kα radiation (λ = 0.71073 Å). The data
were processed and the structure was solved using the APEX-2 software supplied by
Bruker-AXS. The structure was refined by standard difference Fourier techniques with
SHELXL (6.10 v., Sheldrick G. M., and Siemens Industrial Automation, 2000). Hydrogen
atoms were placed in calculated positions using a standard riding model and refined
isotropically; all other atoms were refined anisotropically. The crystals of 6-DMF2 and 7DMF2 were obtained by ether diffusion into saturated DMF solutions of 6 and 7. The
structure of 6-OH2 was obtained by slow evaporation of DMF. The structure of 8 was
obtained by slow diffusion of ether into saturated DMSO solution of 8. The structure of 6DMF2 and 6-OH2 contained two additional DMF molecules per asymmetric unit. The
structure of 8 contained four DMSO molecules, of which two were partially disordered
over two alternative positions.
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Table 3.1. Crystal and structure refinement data 6 - 8.
6-DMF2×2DMF

6-OH2×2DMF

7-DMF2

8×4DMSO

formula

C46H54F6N1O14S2Zn2

C20H22F3N4O7SZn

C22H24F3N4O6SZn

C44H46Br2N6O9S4Zn2

fw

1279.85

584.85

594.88

1221.67

crystal

triclinic

monoclinic

triclinic

monoclinic

P-1

P21/n

C2/c

P21/n

a (Å)

10.5526(10)

15.6178(16)

25.909(3)

13.6493(6)

b (Å)

14.2828(10)

7.5720(8)

9.9629(12)

26.5643(12)

c (Å)

19.042(2)

20.484(2)

23.004(3)

14.3795(7)

α (deg)

101.698(4)

90.00

90.00

90.00

β (deg)

96.853(4)

104.352(5)

123.825(11)

99.272(2)

γ (deg)

101.486(2)

90.00

90.00

90.00

101.486(2)

2346.8(4)

4932.9(10)

5145.7(4)

1.565

1.655

1.602

1.577

Z

2

4

8

4

µ (mm-1)

1.054

1.209

1.149

2.705

T (K)

100(2)

100(2)

100(2)

100(2)

2θ, deg

52.74

52.54

55.20

46.94

R1a (all

4.74

7.28

6.88

7.23

0.0736

0.0801

0.0899

0.1467

3.29

4.01

3.73

5.19

0.0679

0.0733

0.0829

0.1352

1.023

0.903

0.934

1.055

system
space
group

V (Å3)
Dc (g cm
3

-

)

data)
wR2b (all
data)
R 1a
[(I>2σ)]
wR2b
[(I>2σ)]
GOF
a

R1 = S||Fo – |Fc||/S|Fo|. b wR2 = (S(w(Fo2 – Fc2)2)/S(w(Fo2)2))1/2. c GOF = (S w(Fo2 – Fc2)2/(n – p))1/2

where n is the number of data and p is the number of parameters refined.
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CHAPTER 4 INVESTIGATION OF THE REACTIVITY OF HOMODINUCLEAR METAL
COMPLEXES FEATURING REDOX ACTIVE LIGANDS (AND THEIR
MONONUCLEAR ANALOGUES) WITH CARBON DISULFIDE
Portions of this chapter we reprinted or adopted from: Bheemaraju A.; Beattie, J. W.; Lord,
R. L.; Martin, P. D.; and Groysman, S. Chem. Commun. 2012, 48, 9595-9597 and
Bheemaraju A.; Beattie, J. W.; Tabasan, E. G.; Martin, P. D.; Lord, R. L.; and Groysman,
S. Organometallics, 2013, 32, 2952-2962.25, 33 All rights to this work are retained by the
authors and any reuse requires the permission of the authors.
4.1 Introduction
The final objective of my thesis focused on the synthesis and the reactivity of
dinuclear nickel and copper complexes and their mononuclear analogues in the activation
of CS2. As discussed in the introduction, we targeted binding, activation, and cooperative
transformation of CS2, as a model for CO2 chemistry, at dinuclear metal platforms.
Specific reactions of interest to us are (i) reductive coupling that can be achieved via
developing a “radical character” on CS2 carbon in a metal-bound CS2, or (ii) reductive
splitting that occurs via a two-electron reduction of CS2. Our studies focused on the
complexes of Ni and Cu – these metals have previously demonstrated capability to bind
and activate CO2 and CS2. Finally, we utilized redox-active ligands in our research, as
redox-active ligands allow stabilization of highly reduced metal centers (i.e. Ni(0)). Thus,
a significant part of this work was dedicated to the understanding of the interaction of the
reduced Ni centers with redox-active ligands, and the use of such ligands as “electron
storage” accessories in the small-molecule activation reactivity.
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4.2 Synthesis and Characterization of Di-nuclear Ni(0) Complexes and their
Reactivity with CS2
Our original strategy towards the synthesis of the di-CS2 complexes involved initial
synthesis of dinuclear di-Ni(0) complexes of the [Ni2(L)(COD)2] form (L = dinucleating
bis(iminopyridine) ligand; COD = cyclooctadiene), followed by the reaction of these
complexes with two equivalents of CS2. Ni(0) was chosen because it had previously
demonstrated reactivity with heteroallenes.34 Generally, a metal needs to be highly
reducing to bind and activate a heteroallene, and Ni(0) (in the form of Ni(COD)2) provides
useful entry into the chemistry of reduced nickel. In collaboration with a former
postdoctoral associate in our lab, Dr. Amarnath Bheemaraju, a series of dinucleating
ligands (L1, L5 – L10) were synthesized by a simple condensation of one equivalent of pxylylenediamine with 2 equivalents of a substituted pyridine (Figure 4.1). Ligands L1,L5 –
L10 demonstrate varying steric and electronic parameters which can both affect the ability
of the ligand to form Ni(0) complexes and the formation/reactivity of heteroallene
complexes.

Figure 4.1. Synthesis of L1, L5 – L10.
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We attempted to synthesize dinuclear Ni(0) complexes of the [Ni2(L)(COD)2] form
for all ligands L1, L5 – L10 by adding one equivalent of ligand to two equivalents of
Ni(COD)2 in THF. Amar carried out the initial work on L5 and L6, and I continued working
on the other ligands (L1, L7 – L10).25,

35

Upon addition of the ligand to the metal an

immediate color change to a deep purple/blue was observed for all complexes. However,
we were able to isolate the desired [Ni2(L)(COD)2] products only for ligands L1 and L5
(complexes 10 and 11, for the structure of 10, see Figure 4.3). For L6 – L9, we isolated
instead a bis(homoleptic) complexes [Ni2L2] where each Ni center is ligated by the
chelating units of two separate ligands. For L10, we were unable to isolate any identifiable
products. X-ray structures of [Ni2(L1)(COD)2] (Figure 4.3) or [Ni2L2] (not shown here) all
demonstrate significant elongation of the C=N bonds, consistent with partial reduction of
the iminopyridine chelateing unit.12
Following the isolation of complexes 10 and 11, they were treated with two
equivalents of CS2, yielding desired complexes 12 and 13 of the [Ni2(L)(CS2)2] form.
However, it turns out that prior isolation of [Ni2(L)(COD)2] does not constitute a
prerequisite for the attainment of [Ni2(L)(CS2)2] complexes. Thus, a one-pot synthesis
involving dropwise addition of ligands L6 – L9 to the stirring solution of Ni(COD)2 followed
by the addition of CS2 leads to the formation of the desired [Ni2(L)(CS2)2] complexes 14
– 16 (Figure 4.2), obtained by precipitation from a THF solution in good yields.
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Figure 4.2. Synthesis of Complexes 10 – 16.
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Figure 4.3. X-ray structure of 10 (50% probability ellipsoids). Selected bond distances:
C=N (imino) 1.309(2), C – C (imino-pyridine) 1.422(2) Å.
All complexes were characterized by multinuclear NMR spectroscopy, IR
spectroscopy, cyclic voltammetry, and elemental analysis. We have also isolated X-ray
structures for 13 and 14: these are shown in Figure 4.4. Notably, these structures show
two different conformations, syn and anti, that illustrate the flexibility of the open-chain
ligand design. The X-ray structures for 13 and 14 also demonstrate that the two CS2
bonds (of each CS2 fragment) are different. One of the CS2 bonds is significantly
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lengthened signifying its activation. Also of note is that the iminopyridine chelating units
of the dinucleating ligands are fully oxidized: the C=N bond of 1.268(2) Å is consistent
with a usual C=N double bond, while the C-C distance of 1.452(2) Å is close to the value
of C-C single bond in iminopyridine.36 This is significant because in 10 the ligand bonds
demonstrate that it is one electron reduced: the corresponding C=N bond is 1.309(2) Å
and the C-C bond is 1.422(2) Å.

Figure 4.4. X-ray structures of 13 and 14 (50% probability ellipsoids), H atoms removed
for clarity. Selected bond distances for the anti isomer: C=N (imino) 1.309(2) Å; C-C
(iminopyridine) 1.422(2) Å. The R factor for the cis isomer was too high (Rf = 13%) to yield
reliable data.
We have also prepared

13

C-labelled complex 13-13CS2, in order to determine

13

C

chemical shift of the activated CS2 carbon, and to compare its IR spectrum to the IR
spectrum of the unlabeled compound. The 13CS2 signal of 13-13CS2 appears at 268 ppm,
indicating its substantial activation.37 The IR spectra of labeled and unlabeled 13 are given
in Figure 4.5 below. The IR spectrum of unlabeled 13 demonstates two prominent signals
at ca. 1138 cm-1 and 648 cm-1 that shift to 1095 cm-1 and 633 cm-1 upon substitution by
13

CS2. These signals are assigned as C=S and C–S stretches, respectively. The
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significant difference between the double and the single bond is consistent with the
difference in the solid state structure, and with the strong activation of CS2.

Figure 4.5. Comparison between the IR spectra of
(blue) 13.

13

CS2-labeled (red) and unlabeled

4.3 Investigation of the Electronic Structure of the CS2 with Density Functional
Theory
The electronic structure of the iminopyridine nickel CS2 complex was explored by
DFT calculations (Figure 4.6). The DFT calculations reveal that most of the electron
density in HOMO (80) and HOMO-1 (79) is located on the S atoms of the CS2. Only the
HOMO-2 features significant electron density on the Ni. Thus, while formally this system
contains Ni(0) with “neutral” CS2, DFT calculations indicates that the electron density is
localized on the CS2 fragment, suggesting Ni(II) ligated by a doubly reduced CS2. This
finding is consistent with square-planar geometry on the nickel center commonly
observed for the d8 nickel(II) centers. We also note that no frontier orbitals demonstrate
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any participation of the CS2 carbon, which may explain the lack of reactivity at this carbon
(Figure 4.7). Interesting, calculation of the CO2 conformer demonstrates significantly
more electron density on the carbon.

Figure 4.6. Frontier orbital diagram of 13. Doubly occupied and unoccupied orbitals
represented by bolded and non-bolded lines, respectively.
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Figure 4.7. DFT comparison of the HOMO and HOMO+1 of bound CS2 (left) versus CO2
(right).
4.4 Reactivity of di-CS2 Complexes Upon One-Electron oxidation
The reductive coupling of two CS2 fragments to form tetrathiooxalate proceeds
through a one electron reduction at each CS2 fragment followed by C-C bond
formation.20,21 The electronic structure of our CS2 complexes revealed doubly reduced
CS2 fragments. Thus, we decided to oxidize each [Ni-CS2] fragment by one electron
hoping that such oxidation would create a sufficient radical character on CS2 to induce
reductive coupling. To induce this oxidation, complex 13-13CS2 was treated with two
equivalents of [FeCp2](PF6) (Figure 4.8); the reaction was followed by in-situ 13C NMR
spectroscopy.

13

C NMR spectrum of the reaction revealed that upon reaction with

[FeCp2](PF6), CS2 was released. Also, formation of FeCp2 (by 1H and

13

C NMR) and

[Ni(DMF)6](PF6)2 (by X-ray crystallography) was observed. It was not immediately clear
yet whether the reason for the lack of the reductive coupling lies in the electronic structure
of the CS2 adduct (most of the electron density is on the S and not C!) or in the structure
of a dinucleating complex that may not enable a sufficiently close distance between CS2
fragments. To answer this question, we synthesized accurate mononuclear analogues
and investigated their reactivity (see Chapter 4.6).
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Figure 4.8. Oxidation of 13 with [FeCp2](PF6).
4.5 Synthesis of di-Cu(I) Complexes and their Reactivity with CS2
Bouwman and coworkers have demonstrated that a Cu complex is capable of the
reductive coupling of CO2 to form oxalate.23 We also note that Limberg and coworkers
have previously reported activation of CS2 by a related di-Cu(I) complex of a dinucleating
ligand. 38a Therefore, we have also investigated whether Cu(I) complexes of our openchain dinucleating ligands would be able to bind, activate, and couple CS2. We began by
adding one equivalent of L1 to a solution of two equivalents of various Cu(I) precursors
(CuI, CuBr, or Cu(NCMe)4(PF6)) in CH3CN. After allowing the reaction mixture to stir for
one hour, we were able to isolate complexes 17 - 19. The structure of complex 19 (Figure
4.9) demonstrates two tetrahedral Cu(I) centers ligated each by an iminopyridine and two
acetonitrile ligands. 1H NMR spectroscopy suggests that complexes 17 - 19 possess the
same structure in solution where halides serve as counter-ions, and copper(I) centers
bind acetonitrile ligands. Following their isolation, CD3CN solutions of complexes 17 – 19
were treated with two equivalents of CS2, and 1H NMR spectra were taken after stirring
the solutions for 24 h. The spectra (see Figure 4.10 for the reactivity of complex 19)
demonstrates little change therefore suggesting the complexes 17-19 do not react with
CS2 (Figure 4.10).
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Figure 4.9. X-ray structure of 19; H atoms and counterions (PF6) are omitted for clarity.

Figure 4.10. 1H NMR Comparison of 17 with 17 + CS2
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4.6 Mononuclear Ni(0) Complexes with CS2 and their Reactions with One-electron
Oxidants and Reductants
As aforementioned, it was not clear whether the inability of the Ni-CS2 complexes
to undergo the reductive coupling results from their unfavorable dinuclear structure, or
from their intrinsic electronic structure. The additional problem encountered with these
species was their low solubility in common organic solvents, thus limiting our choice of
the reaction solvent to the most polar solvents (DMF, DMSO, or CH3CN in selected
cases), which can serve as ligands competing with CS2. These reasons led us to
investigate their mononuclear analogues. Two mononucleating ligands (L11,L12) were
synthesized, following similar protocols as for the synthesis of dinucleating ligands
(Figure 4.11). L11 features an iminopyridine with a benzyl group on the imine nitrogen,
L12 features an iminopyridine with a 2,6-diisopropylphenyl group on the imine nitrogen.
While L11 serve as an accurate steric and electronic mononuclear analogue of L5, L12
serves as the more soluble variant. Following a similar approach to the synthesis of
dinuclear complexes, we also synthesized Ni(L)(COD) adducts (complexes 20 and 21)
by treating Ni(COD)2 with L (Figure 4.11). We have isolated X-ray quality crystals for 20
and 21. The structure of 21 is shown in Figure 4.12. Next, we treated compounds 20 and
21 with CS2 to form complexes 22 and 23. The structure of complex 22 is also given in
Figure 4.12.
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Figure 4.11. Synthesis of mononuclear Ni(0) complexes.

Figure 4.12. X-ray crystal structures of 21 and 22 (50% probability ellipsoids).
In order to probe the ability of these mononuclear systems to reductively couple
CS2 fragments, we reacted them with one-electron oxidants and reductants. Since these
systems show a much higher level of solubility than their dinuclear counterparts, we
hoped that the mononuclear counterparts would show reactivity where the dinuclear
systems did not. We first treated complex 22 with Fe(Cp)2PF6, a suitable one electron
oxidant. These results can be seen in Figure 4.13. The top 13C NMR spectra shows the
highly activated C peak of the CS2 fragment at 267 ppm. After addition of the oxidant, it
can be seen in the bottom spectra that the peak at 267 ppm completely disappears and
a new peak at 193 ppm corresponding to unbound 13CS2 can be seen. Thus, mononuclear
analogues display similar behavior to the dinuclear one, suggesting that CS2 does not
undergo coupling due to its side-on electronic structure. The reduction reaction of 22 with
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KC8 showed complete liberation of the ligand L12. We were not able to isolate other
products from this reaction.
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Figure 4.13. Top 13C NMR of 22 with 13C labeled CS2, bottom 13C NMR of the reaction of
22+ Fe(Cp)2PF6 with toluene standard.
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4.7 Summary and Conclusion
A series of dinucleating bis(iminopyridne) ligands containing para-xylylene linkers
was synthesized. Using these ligands, we synthesized dinuclear di-Ni(0) and di-Cu(I)
complexes. While the Ni(0) complexes were able to bind and activate CS2, the Cu(I)
complexes were unable to do the same. The electronic structure of the bound CS2
features a doubly reduced heteroallene side-on bound to a square planar Ni(II). No
reductive coupling of splitting of CS2 was observed upon one-electron oxidation.
Investigation of the reactivity of accurate mononuclear Ni-CS2 analogues revealed that
the lack of the reductive coupling of side-on bound CS2 stems from its intrinsic electronic
structure and not from the unfavorable disposition of the Ni-CS2 fragments in the dinuclear
complex.
4.8 Experimental Details
All reactions involving air-sensitive materials were executed in a nitrogen-filled
glovebox.

p-Xylylenediamine,

6-(4-methoxyphenyl)-2-pyridinecarboxaldehyde,

methoxy-2-pyridinecarboxaldehyde,
bromopyridine-6-carboxaldehyde,

4-(6-formylpyridin-2-yl)benzonitrile,
2,4,6-triisopopylphenylboronic

(trifluoromethyl)pyridine-2-carboxaldehyde,

acid,

bis(cyclooctadiene)nickel(0)

626-

(Ni(COD)2),

carbon disulfide, and 13C-labeled carbon disulfide were purchased from Aldrich, Strem or
TCI America and used as received. All solvents were purchased from Fisher scientific
and were of HPLC grade. The solvents were purified using an MBRAUN solvent
purification system and stored over 3-Å molecular sieves. Compounds were routinely
characterized by

1

H,

13

C {H} NMR (13C NMR thereafter) and

19

F NMR, X-ray

crystallography, and elemental analyses. Selected compounds were characterized by
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mass spectrometry (ESI). NMR spectra of all compounds were recorded at the Lumigen
Instrument Center (Wayne State University) on a Varian Mercury 400 NMR Spectrometer
in C6D6, (CD3)2SO or CD2Cl2 at room temperature. Chemical shifts and coupling
constants (J) were reported in parts per million (δ) and Hertz respectively. Low resolution
mass spectra were obtained at the Lumigen Instrument Center utilizing a Waters
Micromass ZQ mass spectrometer (direct injection, with capillary at 3.573 (KV) and cone
voltage of 20.000 (V)). Only selected peaks in the mass spectra are reported below.
Elemental analyses were performed by Midwest Microlab LLC or Columbia Analytical
Services, Inc.
L5, L6, L11 and Ni2L5COD2 were prepared according to previously published
procedures.35, 38
Synthesis

of

L8.

A

50

mL

methanol

solution

of

6-(4-methoxyphenyl)-2-

pyridinecarboxaldehyde (3.61 g, 33.8 mmol) was added to a 50 mL methanol solution of
p-xylylenediamine (2.3 g, 16.9 mmol). The resulting solution was stirred and refluxed for
4h. A white cloudy reaction mixture was cooled to room temperature. A white solid was
isolated by filtration and dried to give L8 (4.28 g, 81%). 1H NMR (CD2Cl2, 400 MHz) δ 8.55
(s, 2H), 8.01 (d, J = 8.4 Hz, 4H), 7.92 (d, J = 6.4 Hz, 2H), 7.77 (t, J = 7.2 Hz, 2H), 7.71 (d,
J = 7.6 Hz, 2H), 7.37 (s, 4H), 6.99 (d, J = 7.2 Hz, 4H), 4.87 (d, J = 7.6 Hz, 4H), 3.86 (s,
6H);

13

C NMR (CD2Cl2, 75 MHz) δ 163.89, 161.21, 156.96, 155.03, 138.59, 137.70,

131.96, 128.85, 128.62, 121.03, 119.08, 114.55, 65.16, 55.86. HRMS (ESI) calcd for
[C34H30N4O2+H]+ 527.2447, found 527.2438. Mp: 204 °C.
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Synthesis of L9. A 10 mL methanol solution of 6-methoxy-2-pyridinecarboxaldehyde (250
mg, 1.82 mmol) was added to a 10 mL methanol solution of p-xylylenediamine (124 mg,
0.910 mmol). The resulting solution was stirred and refluxed for 4 h. The reaction mixture
was cooled to room temperature. White powder was separated from the solution by
filtration, washed with cold methanol, and dried to yield L9 (308 mg, 91%) as a white solid.
1

H NMR (C6D6, 400 MHz) δ 8.36 (s, 2H), 7.79 (d, J = 7.6 Hz, 2H), 7.25 (s, 4H), 7.01 (t, J

= 8.0 Hz, 2H), 6.54 (d, J = 8.0 Hz, 2H), 4.60 (s, 4H), 3.81 (s, 6H);

13

C NMR (C6D6, 75

MHz) δ 164.66, 163.0, 153.43, 139.28, 138.76, 128.96, 114.52, 112.69, 64.21, 53.44.
HRMS (ESI) calcd. for [C22H22N4O2+H]+ 375.1821, found 375.1821. Mp: 121 °C.
Synthesis of L10. A 50 mL solution of 6-(trifluoromethyl)-2-pyridinecarboxaldehyde (1.00
g, 5.71 mmol) was added to a 50 mL methanol solution of p-xylylenediamine (0.389 g,
2.85 mmol). The resulting solution was stirred and refluxed for 4 h. The reaction mixture
was cooled to room temperature. White precipitate was separated from the solution by
filtration, washed with cold methanol, and dried to give L10 (1.01 g, 79%). 1H NMR (C6D6,
400 MHz) δ 8.26 (s, 2H), 7.94 (d, J = 8.0 Hz, 2H), 7.19 (s, 4H), 6.99 (d, J = 7.6 Hz, 2H),
6.82 (t, J = 8.0 Hz, 2H), 4.49 (d, J = 7.2 Hz, 4H);

13

C NMR (C6D6, 75 MHz) δ 161.95,

155.96, 148.40, 148.06, 138.42, 137.93, 129.02, 123.67, 121.43, 121.41, 65.02; 19F NMR
(C6D6, 400 MHz) δ -67.75; HRMS (ESI) calcd for [C22H16N4F6+H]+ 451.1357, found
451.1362. Mp: 146 °C.
Synthesis of Ni2(L1)(COD)2 (10). The suspension of L1 (33 mg, 0.046 mmol) in 3 mL of
THF was added at RT to a 3 mL solution of Ni(COD)2 (28 mg, 0.10 mmol) in THF. The
reaction was left to stir for 24 h to obtain a dark purple solution. The solvent was removed
under vacuum. The resulting solid was dissolved in hexane (10 mL) and the solvent was
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removed. Recrystallization of the product from ether at -35 °C over two days yielded
Ni2(L4)(COD)2 as purple crystals (19 mg, 0.018 mmol, 39% yield). 1H NMR (C6D6, 400
MHz) δ 8.56 (s, 2H), 7.44 (t, J = 7.6 Hz, 2H), 7.40 (s, 4H), 7.33 (dd, J = 5.6 Hz, 1.2 Hz,
2H), 7.30 (s, 4H), 6.91 (dd, J = 6.8 Hz, 0.8 Hz, 2H), 5.57 (s, 4H), 3.90 (s, 8H), 3.06 (m,
4H), 2.97 (m, 2H), 2.67 (m, 4H), 1.62-1.50 (m, 8H), 1.27 (dd, J = 20.0 Hz, 6.4 Hz, 24H),
1.13 (d, J = 6.4 Hz, 12H);

13

C NMR (C6D6, 75 MHz) δ 161.68, 150.15, 149.04, 147.56,

146.03, 140.66, 138.12, 129.14, 128.85, 128.62, 128.14, 125.80, 125.35, 124.52, 121.50,
90.02, 83.10, 81.51, 66.28, 66.25, 35.53, 31.37, 31.20, 30.67, 30.52, 28.71, 27.50, 24.90,
22.01, 15.93. MS (ESI) calcd for Ni2(L1)(COD) ([C58H74N4Ni2]+) 942.4620 found 942.5277.
Anal. Calcd for C66H86N4Ni2: C, 75.3; H, 8.2; N, 5.3. Found: C, 75.1; H, 8.0; N, 5.4.
Synthesis of Ni2(L1)(CS2)2 (12). The suspension of L1 (34 mg, 0.047 mmol) in 3 mL of
THF was added at RT to a 3 mL solution of Ni(COD)2 (26 mg, 0.095 mmol) in THF. To
the resulting mixture, CS2 was added (0.095 mmol, 0.67 mL, 0.15 M in THF). The reaction
was left to stir for 24 h to obtain a dark-blue solution. The solvent was removed under
vacuum. The resulting solid was washed successively with hexane (10 mL), ether (3 mL),
and toluene (3 mL), and dried to afford Ni2(L1)(CS2)2 (22 mg, 0.022 mmol, 47%). 1H NMR
(DMSO-d6, 400 MHz) δ 8.99 (s, 2H), 8.19 (t, J = 7.2 Hz, 2H), 7.95 (d, J = 8.0 Hz, 2H),
7.84 (d, J = 8.4 Hz, 2H), 7.45 (s, 4H), 7.07 (s, 4H), 5.40 (s, 4H), 2.91 (m, 2H), 2.24 (m,
4H), 1.15-1.25 (m, 24H), 1.00 (d, J = 8.0 Hz, 12H); 13C NMR (DMSO-d6, 75 MHz) δ 265.44
(also peak for unbound

13

CS2 at δ 192.62 is due to decomposition of the product in

DMSO-d6) Anal. Calcd for C52H62N4Ni2S4: C, 63.2; H, 6.3; N, 5.7. Found: C, 63.1; H, 6.2;
N, 5.5.

76

Synthesis of Ni2(L5)(CS2)2 (13). A 1.5 M THF solution of CS2 (0.15 mL, 0.231 mmol) was
added to a 5 mL violet-blue THF solution of Ni2(L5)(COD)2 (11, 75 mg, 0.115 mmol). A
precipitate was obtained after the addition of CS2. The reaction was stirred for 15 min,
and the solid was removed from the reaction mixture and washed with ether. Removal of
the supernatant followed by drying gave purple-brown solid (60 mg, 88%). The

13

C-

labeled sample was prepared in an identical fashion. 1H NMR (DMSO-d6, 400 MHz) δ
9.44 (d, J = 4.8 Hz, 2H), 8.90 (s, 2H), 8.23 (t, J = 7.6 Hz, 2H), 7.96 (d, J = 8.0 Hz, 2H),
7.90 (t, J = 6.4 Hz, 2H), 7.51 (s, 4H), 5.23 (s, 4H); 13C NMR (DMSO-d6, 75 MHz) δ 267.87
(13CS2). MS (ESI) calcd for [Ni2(L1)(CS2)2]+ 581.9, found 581.8; [Ni2(L1)(CS2)]+ 505.9,
found 505.8. IR (cm–1,

12

CS/13CS signals): 1138/1095 (s), 648/633 (s). Anal. Calcd for

C22H18N4Ni2S4: C, 45.24; H, 3.11; N, 9.59. Found: C, 44.97; H, 3.27 N, 9.32.
Synthesis of Ni2(L6)(CS2)2 (14). The solution of L6 (50 mg, 0.15 mmol) in 3 mL of THF was
added at RT to a 3 mL solution of Ni(COD)2 (80 mg, 0.29 mmol) in THF. The resulting
mixture was allowed to stir for 2 hours. After that, CS2 was added (0.29 mmol, 0.34 mL,
0.83 M in THF) causing precipitation of purple solid, and the resulting mixture was allowed
to stir overnight. Purple solid was separated from the solution, washed with ether (10 mL)
and dried to yield pure Ni2(L6)(CS2)2 (86 mg, 0.14 mmol, 94%). 1H NMR (DMSO-d6, 400
MHz) δ 9.50 (m, 2H), 8.24 (t, J = 8.0 Hz, 2H), 8.09 (d, J = 8.0 Hz, 2H), 7.89 (t, J = 6.4 Hz,
2H), 7.48 (s, 4H), 5.32 (s, 4H), 2.46 (s, 6H);
(corresponding

to

13

CS2

in

13

Ni2(L6)(CS2)2).

C NMR (DMSO-d6, 75 MHz) δ 270.56
MS

(ESI)

calcd

for

Ni2(L6)(CS2)
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([C23H22N4Ni2S2+H]+) 535.01 found 534.81. Anal. Calcd for C24H22N4Ni2S4: C, 47.1; H,
3.6; N, 9.2. Found: C, 47.1; H, 3.7; N, 9.1.
Synthesis of Ni2(L7)(CS2)2 (15). The suspension of L7 (64 mg, 0.12 mmol) in 3 mL of THF
was added at RT to a 3 mL solution of Ni(COD)2 (65 mg, 0.24 mmol) in THF in the course
of 1 h, and the reaction mixture was allowed to stir for additional hour. To the resulting
purple solution CS2 was added (0.095 mmol, 0.67 mL, 0.15 M in THF), leading to the
formation of dark precipitate. The reaction was left to stir for 12 h. Ether (10 mL) was
added, and dark-brown solid was separated. The solid was washed with THF (15 mL)
and ether (10 mL) and dried to afford Ni2(L7)(CS2)2 (49 mg, 0.064 mmol, 53% yield). 1H
NMR (DMF-d7, 400 MHz) δ 8.62 (s, 2H), 8.17 (d, J = 8.0 Hz, 4H), 8.03 (m, 2H), 7.96 (m,
4H), 7.45 (s, 4H), 7.11(d, J = 8.0 Hz, 4H), 4.94 (s, 4H), 3.89 (s, 6H);

13

C NMR (DMSO-

d6, 75 MHz) δ 264.41. Anal. Calcd for C36H30N4Ni2O2S4: C, 54.3; H, 3.8; N, 7.0. Found:
C, 53.9; H, 3.5; N, 6.6.
Reaction of Ni2(L6)(13CS2)2 (14) with (FeCp2)(PF6). The purple suspension of
Ni2(L6)(13CS2)2 (16 mg, 0.026 mmol) in 2 mL of CD3CN was treated at RT with blue
solution of (FeCp2)(PF6) (1 equiv, 17 mg, 0.026 mmol) in CD3CN (1 mL). The color
changed to brown. The resulting mixture was allowed to stir for 1 h. The reaction was
followed by 1H and

13

C NMR. 1H NMR (CD3CN, 400 MHz) spectrum showed a single

resonance attributable to FeCp2 at δ 4.16. The
resonances, attributable to
respectively.

13

13

C NMR (CD3CN, 75 MHz) showed two

CS2 and Fe(C5H5)2, observed at δ 193.65 and 68.81 ppm
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Synthesis of Cu2L1(CH3CN)4(PF6)2 (17) – To a 2 mL solution of Cu(CH3CN)4(PF6) (27.3
mg, 0.0834 mmol) in CH3CN a 2 mL solution of L1 in THF was added. (30.0 mg, 0.0417
mmol). The solution was allowed to stir for one hour. The resulting solution was then
filtered and the solvent removed from the filtrate under vacuum yielding an orange solid.
X-ray quality crystals were obtained by vapor diffusion of diethyl ether into CH3CN.
Yielding [Cu2(L1)(CH3CN)4](PF6)2 in 76% yield. 1H NMR (400 MHz, CD3CN) δ 8.64 (s,
2H), 8.12 (t, J = 8.0 Hz, 2H), 7.85 (d, J = 8.0 Hz, 2H), 7.70 (d, J = 8.0 Hz, 2 H), 7.45 (s,
4H), 7.18 (s, 4H), 4.97 (s,4H), 2.99 (m, 1H), 2.31 (m, 1H), 1.96 (s, 12H), 1.31 (d, J = 7.2
Hz, 12H), 1.13 (d, J = 6.4 Hz, 12H), 1.01 (d, J = 7.2 Hz, 12H).

19

F NMR (CD3CN, 400

MHz) δ -71.954.
Synthesis of Cu2(L1)Br2 (18) – To a 3 mL solution of CuBr in methylene chloride (12.0 mg,
0.0556 mmol) a 2 mL solution of L1 (20.0 mg, 0.0278 mmol) in methylene chloride was
added. The resulting solution was allowed to stir for 12 h. The solvent was removed under
vacuum. The product was recrystallized by vapor diffusion of ether into methylene
chloride, yielding Cu2(L1)Br2 in 68%. 1H NMR (400 MHz, CD3CN) δ 8.64 (s, 2H), 8.12 (t,
J = 8.0 Hz, 2H), 7.85 (d, J = 8.0 Hz, 2H), 7.70 (d, J = 8.0 Hz, 2 H), 7.45 (s, 4H), 7.18 (s,
4H), 4.97 (s, 4H), 2.99 (m, 1H), 2.31 (m, 1H), 1.96(s, 12H), 1.31 (d, J = 7.2 Hz, 12H), 1.13
(d, J = 6.4 Hz, 12H), 1.01 (d, J = 7.2 Hz, 12H).
Synthesis of Cu2(L1)I2 (19) – To a 3 mL solution of CuI in methylene chloride (11.0 mg,
0.0556 mmol) a 2 mL solution of L1 (20.0 mg, 0.0278 mmol) in methylene chloride was
added. The resulting solution was allowed to stir for 12 h. The solvent was removed under
vacuum. The product was recryatillized by vapor diffusion of ether into methylene
chloride. Yielding LCu2I2 in 73% yield .1H NMR (400 MHz, CD2Cl2) δ 8.42 (s, 2H), 7.92 (t,
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J = 7.6 Hz, 2H), 7.89 (d, J = 7.2 Hz, 2H), 7.52 (d, J = 8.0 Hz, 2H), 7.37 (s, 4H), 7.06 (s,
4H), 4.87 (s, 4H), 2.94 (m, 2H), 2.34 (m, 4H), 1.28 (d, J = 7.2 Hz, 12H), 1.04 (d, J = 6.4
Hz, 24H).

13

C NMR (CD2Cl2, 75 MHz) δ 157.42, 146.67, 121.33, 95.253, 35.04, 31.05,

24.79, 24.46.
Reaction of (L1)Cu2I2 (19) with CS2 - To a 3 mL solution of CuI in CD3CN (11.0 mg, 0.0556
mmol) a 2 mL solution of L1 (20.0 mg, 0.0278 mmol) in CD3CN was added. The resulting
solution was allowed to stir for 1 h at which point 0.566 mL of a 0.1 M solution of CS2 in
methylene chloride was added. The mixture was allowed to stir for 12 h, the solvent was
removed under reduced pressure and NMR taken.
Synthesis of L11 – 2-pyridinecarboxyaldehyde (0.143 mL, 1.5 mmol) was added to 10 mL
of ethanol at which point 2,6-diisopropylaniline (0.283 mL, 1.5 mmol) was added to the
solution. A catalytic amount of acetic acid was then added to the ethanol solution. The
resulting solution was then allowed to stir for 12 h at which point the solvent was removed
under reduced pressure yielding L11 in quantitative yield (399 mg, 100% yield) 1H NMR
(400 MHz, C6D6) δ 8.59 (s, 1H), 8.46 (d, J = 4.4 Hz, 1H), 8.277 (d, J = 8.0 Hz, 1H), 7.11
(t, J = 9.6 Hz, 1 H) 6.64 (m, 1 H), 3.14 (qt, J = 6.8 Hz, 2 H) 1.15 (d, J = 6.8 Hz, 12 H). 13C
NMR (DMSO-d6, 75 MHz) δ 163.26, 153.57, 149.15, 148.15, 137.20, 136.53, 125.92,
124.35, 122.89, 120.83, 66.99, 27.482, 25.11, 23.16.
Synthesis of Ni(L11)(COD) (20). A solution of L11 (53 mg, 0.27 mmol) in 5 mL of THF was
added dropwise at room temperature to a 5 mL solution of bis(cyclooctadiene)nickel(0)
(Ni(COD)2) (103 mg, 0.374 mmol) in THF. The resulting violet-blue colored reaction
mixture was stirred for 1 h, and the solvent was removed in vacuo. Crystallization from
hexanes resulted in violet-blue crystalline solid (70 mg, 71 %). 1H NMR (C6D6, 400 MHz)
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δ 10.10 (d, J = 6.8 Hz, 1H), 8.23 (s, 1H), 7.31-7.27 (m, 2H), 7.23-7.18 (m, 2H), 7.17-7.10
(m, 2H), 7.07 (m, 1H), 6.92 (dt, J = 8.0 Hz, 1.2, 1H), 5.29 (s, 2H), 3.77 (m, 2H), 3.70 (m,
2H), 2.74 (m, 2H), 2.51 (m, 2H), 1.74-1.57 (m, 4H);

13

C NMR (C6D6, 75 MHz) δ 152.22,

147.96, 142.60, 139.86, 128.60, 128.42, 127.63, 127.44, 127.16, 125.47, 118.98, 82.97,
82.06, 66.38, 31.36, 31.32. Anal. Calcd for C21H24N2Ni·C4H10O: C, 68.67; H, 7.84; N,
6.41. Found: C, 68.19; H, 6.65; N, 6.03.
Synthesis of Ni(L12)(COD) (21)– A 0.500 M solution of L12 in THF (0.200 mL, 0.100 mmol)
was added to a stirring solution of bis(cyclooctadiene)nickel(0) (Ni(COD)2) (28.0 mg,
0.100 mmol) in THF. The resulting solution was allowed to stir for 1 h. The solvent was
then removed from the resulting purple solution. Crystallization from hexanes resulted in
L12NiCOD as a purple solid (30.0 mg, 69%). 1H NMR (C6D6, 400 MHz) δ 10.16 (s, 1 H),
8.60 (s, 1H), 7.31 (m, 2H), 7.14 (m, 2H), 3.87 (d, 2H), 3.26 (q, 1H), 2.85 (m, 1 H), 2.387
(s, 2H), 1.68 (d, 2H), 1.34 (d, 6H), 0.96 (d, 6H).

13

C NMR (C6D6, 75 MHz) δ 152.921,

148.88, 140.68, 140.40, 127.34, 126.21, 118.88, 85.39, 31.41, 31.21, 28.136, 27.361,
23.22.
Synthesis of Ni(L11)(CS2) (23). A 0.083 M solution of CS2 (1.38 ml, 0.115 mmol) in THF,
was added to the 3 mL of violet-blue Ni(L11)(COD) (60 mg, 0.165 mmol) solution in diethyl
ether. A precipitate was obtained after the addition of the CS2 solution. An additional 4
mL of diethyl ether was added to the reaction mixture and it was stirred for 10 minutes.
Crystallization of the insoluble precipitate using CH3CN and ether resulted in a crystalline
purple-brown solid (32 mg, 84 %). 1H NMR (DMSO-d6, 400 MHz) δ 9.47 (d, J = 4.8, 1H),
8.93 (s, 1H), 8.22 (t, J = 7.6 Hz, 1H), 7.98 (d, J = 7.6 Hz, 1H), 7.91 (t, J = 6.4, 1H), 7.48
(d, J = 7.2 Hz, 2H), 7.41-7.27 (m, 3H), 5.23 (m, 2H);

13

C NMR (DMSO-d6, 75 MHz) δ
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267.90 (13CS2), 165.75, 152.50, 148.36, 138.63, 136.36, 130.76, 128.48, 128.33, 128.12,
128.05, 127.27, 126.33, 62.10. MS (ESI) calcd for [Ni(L11)]+ 254.03, found 253.11. We
were not able to observe the parent ion in the mass spectrum. The compound is unstable,
decomposing over time as demonstrated below. The attempted EA shows low carbon
percentage. Anal. Calcd for C14H12N2NiS2: C, 50.79; H, 3.65; N, 8.46. Found: C, 46.34;
H, 3.52; N, 7.24.
Synthesis of Ni(L12)(CS2) (24) – To a 3 mL stirring solution of Ni(L12)(COD) (30.0 mg,
0.0692 mmol) in hexanes was added a 0.0883 M solution of CS2 (0.083 mL, 0.0692 mmol)
in hexanes. After 1 h, a black solid forms. The solvent of the slurry is removed and washed
with 40 mL of hexanes, giving a black/blue solid Ni(L12)(CS2). 1H NMR (C6D6, 400 MHz)
δ 8.60 (s, 1H), 8.47 (s, 1H), 8.29 (d, J = 7.6, 1H) 6.82 (m,1H), 6.66 (m, 2H), 6.35 (d, J =
7.6 Hz, 1H), 3.163 (m, 2H), 1.16 (d, 12H).
Reaction of NiL11(CS2) (23) + Fe(Cp)PF6 – This reaction was performed according to the
one reported above for the dinuclear complex with toluene added as a standard.
Reaction of NLi12CS2 (24) + KC8 – To a slurry of KC8 (3.8 mg, 0.0282 mmol) in C6D6 was
added a solution of NiL9CS2 (11.3 mg, 0.0282 mmol). The slurry was allowed to stir for
one hour. The rxn was then filtered and NMR taken. The resulting NMR showed only
peaks of liberated ligand.
X-ray Crystallographic Details
Structures of compounds were confirmed by X-ray analysis; structures of 10 and
11 were previously reported. Table 4.1 presents selected structural and refinement data
for compounds L7, 10, 13, 14, 20, and 23. The crystals were mounted on a Bruker
APEXII/Kappa three circle goniometer platform diffractometer equipped with an APEX-2
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detector. A graphic monochromator was employed for wavelength selection of the Mo
Kα radiation (λ = 0.71073 Å). The data were processed and refined using the program
SAINT supplied by Siemens Industrial Automation. Structures were solved by direct
methods in SHELXS and refined by standard difference Fourier techniques in the
SHELXTL program suite (6.10 v., Sheldrick G. M., and Siemens Industrial Automation,
2000). Hydrogen atoms were placed in calculated positions using the standard riding
model and refined isotropically; all other atoms were refined anisotropically. In the
structure of 10, Ni2(L1)(CS2)2 occupies a special position. The structure of 10 contained
two crystalographically independent molecules of Ni(L2)(CS2), displaying slightly different
metrics The asymmetric unit of L4, 10, and 13 contains only half of the centrosymetric
molecule. The structure of 3b was of somewhat low quality due to the poorly diffracting
crystals. The structure contained two methoxy groups that were found to be disordered
over two positions. The disorder was satisfactorily modeled. In addition, the structure
contained one hexane molecule per asymmetric unit. The structure of 4a contained one
ether molecule. The structure of 10 contained three partially disordered solvent molecules
that have been modeled as hexane (crystallization solvent) with partial occupancies. The
structure of 12 was of very low quality due to the small crystal size, poor diffraction, and
twinned nature of the crystals. Therefore, only the overall connectivity and the
approximate metal-metal separation of 12 are discussed.
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Table 4.1. Crystal and structure refinement data.
L7
14
formula
C11H11N2
C24H22N4Ni2S4
Fw, g/mol
171.22
612.11
temperature
100(2) K
100(2) K
cryst syst
triclinic
monoclinic
space group
P-1
P21/n
color
colorless
purple
Z
2
4
a, Å
6.527(1)
9.204(1)
b, Å
7.3600(8)
17.587(3)
c, Å
9.897(1)
15.385(2)
α, deg
75.784(7)
90.00
β, deg
77.753(6)
93.694(7)
γ, deg
73.444(7)
90.00
3
V, A
436.6(1)
2485.4(7)
3
dcalcd, g/cm
1.302
1.721
μ, mm-1
0.079
1.883
2θ, deg
50.00
48.00
a
R1 [(I>2σ)]
0.0600
0.1366
wR2b [(I>2σ)] 0.1866
0.3172
GOF (F2)
a

1.347

1.092

10
C37H53N2NiO
1134.99
100(2) K
monoclinic
P21/c
purple
4
23.353(3)
14.377(2)
10.036(1)
90.00
95.632(4)
90.00
3353.4(6)
1.189
0.608
55.10
0.0448
0.1018

13
C11H9N2NiS
292.03
100(2) K
monoclinc
P21/n
black
4
7.2464(7)
10.7305(9)
14.446(1)
90.00
94.265(5)
90.00
1120.14(2)
1.732
2.073

1.052

1.071

0.0695
0.1731

R1 =1/2S||Fo – |Fc||/S|Fo|. b wR2 = (S(w(Fo2 – Fc2)2)/S(w(Fo2)2))1/2. c GOF = (S w(Fo2 – Fc2)2/(n
– p)) where n is the number of data and p is the number of parameters refined.
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Table 4.1 (Continued from the previous page). Crystal and structure refinement data.
20
22
23
19
formula
Fw, g/mol
temperature
cryst syst
space group
color
Z
a, Å
b, Å
c, Å
α, deg
β, deg
γ, deg
V, A3
dcalcd, g/cm3
μ, mm-1
R1a [(I>2σ)]
wR2b [(I>2σ)]

a

C21H24N2Ni
363.13
100(2) K
monoclinic

C28H24N4Ni2S4
662.17
100(2) K
triclinic

Purple
8
25.286(3)
7.3278(6)
21.348(2)
90.00
120.423(8)
90.00
3411.0(6)
1.414
1.141
0.0258
0.0710

Blue
2
8.7358(7)
9.5434(7)
17.008(1)
98.210(5)
98.742(5)
90.00
1373.60(19
1.601
1.701
0.0712
0.2004

C52H68N4Ni2
866.53
100(2) K
triclinic
P-1
Purple
1
8.7160(7)
11.6166(9)
11.8182(8)
105.905(4)
100.212(4)
93.813(4)
1124.15(15)
1.280
0.877
0.0470
0.1403

C58H74Cu2F12N8P2
1300.27
100(2) K
triclinic
P-1
Orange
2
13.2536(6)
15.5031(9)
17.0082(10)
63.627(2)
85.315(2)
84.878(2)
3115.0(3)
1.386
0.813
0.0618
0.0904

R1 = S||Fo – |Fc||/S|Fo|. b wR2 = (S(w(Fo2 – Fc2)2)/S(w(Fo2)2))1/2. c GOF = (S w(Fo2 – Fc2)2/(n
– p))1/2 where n is the number of data and p is the number of parameters refined.
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CHAPTER 5 SUMMARY, CONCLUSIONS AND FUTURE DIRECTIONS
5.1 Summary and Conclusions
There is a growing interest in the synthesis and applications of dinuclear metal
complexes due to a possible cooperativity between the two metal centers. Two specific
applications of dinuclear metal complexes were investigated in this dissertation: oxalate
sensing (Chapters 2 and 3), and cooperative reductive coupling of CS2 (Chapter 4)
Toward these goals, new open-chain and macrocyclic bimetallics were synthesized and
their reactivity in the aforementioned reactions was interrogated.
In Chapter 2 a new bimetallic d-dinickel complex of an open-chain highly flexible
dinucleating ligands was designed and investigated as a sensor for oxalate. The complex
was able to bind oxalate intramolecularly, between the two nickel centers. Furthermore,
oxalate binding to the complex induced color change from pink to green. Thus, this
complex enables colorimetric sensing of oxalate, obviating the need for expensive
fluorescence sensors. The binding constant for oxalate was found to be 5.2 x 102 M-1,
which is lower than in most previously investigated samples. However, in spite of this
relatively low value, the sensor was found to be selective for oxalate versus most other
carboxylates. In order to determine selectivity, a novel convenient method was employed,
relying on the use of mass spectrometry. Due to the relative low binding affinity (for
oxalate), our new sensor was also proven to be the first “reusable” sensor. The oxalatebound form of the sensor can be conveniently transformed into the oxalate-free form by
the addition of stoichiometric quantities of calcium bromide, that forms insoluble calcium
oxalate and an oxalate-free sensor
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In Chapter 3 we discussed the design and application of the significantly more
rigid macrocyclic Schiff-base systems in oxalate sensing. The systems under
investigation were synthesized in a one-pot template synthesis using oxalate as a
template. We postulated that a system that uses oxalate as a template for its assembly
would have high affinity and selectivity for oxalate. A series of complexes wassynthesized
featuring two slightly different linkers (p-xylylene and m-xylylene) and chelating groups
(bis(aldimino)pyridine and bis(ketimino)pyridine) to modulate the metal-metal distance.
We observed that the ability of the macrocycle to fold into different conformations kept
this distance relatively static. All attempts at oxalate extraction were unsuccessful except
the case where HCl was used. In this case, the oxalate-free product was observed in
mass spectra, however, we were not able to isolate and further characterize it due to the
ensuing hydrolysis of the macrocycle. Thus, we conclude that the open-chain flexible
bimetallics, despite not binding oxalate as strongly as macrocycles, are more useful
oxalate sensors, allowing (1) colorimetric detection of oxalate; (2) reversibility in oxalate
binding and reusability of the sensor.
In Chapter 4 we presented di-Ni(0) and Cu(I) complexes and mononuclear
analogues. These systems were designed to test possible side-by-side binding and
ensuing cooperative activation of heteroallenes, exemplified by carbon disulfide. The dinickel bis(iminopyridine) complexes led to the bis-CS2 adducts Ni2(L)(CS2)2 (L =
dinucleating bis(iminopyridine) ligand). For comparison, we have also synthesized
accurate mononuclear analogues Ni(L)(CS2)2 (L = iminopyridine). The electronic structure
of these adducts and the role of the redox-actiive iminopyridines in heteroallenes
activation was thoroughly investigated. In contrast, no CS2 adducts with the di-Cu(I)
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complexes were observed. All attempts to cause reductive coupling between Ni-CS2
fragments were unsuccessful in both the dinuclear and mononuclear complexes despite
significant activation of bound CS2, suggesting that it is the specific binding mode of CS2
(side-on) that prevent its reductive coupling.
5.2 Future Work
The major drawback of our macrocycle systems as oxalate sensors lies in the
presence of Schiff-base functionalities, that are incompatible with the strongly acidic
reagents required for oxalate extraction. Furthermore, this functionalities induce
excessive rigidity in the system that make oxalate binding “too perfect”. On the other hand,
the selectivity of the open-chain system was imperfect, due to its excessive flexibility. A
reasonable compromise between the two systems would be a macrocyclic system with
reduced Shiff-base functionalities. Thus, future work in this project will focus on the
related amino-linked macrocycles, which will possess correct metal-metal distances for
selective oxalate binding combined with increased rigidity and stability under harsh acidic
conditions.
The major pitfall of the bidentate iminopyridine chelate was that it enables
unproductive side-on (η2) coordination of CS2 at square-planar Ni(II) center. We showed
that this binding mode did not lead to a productive chemistry at the CS2 carbon. We
postulate that CS2 (or CO2 down the road) binding mostly through carbon may enable
carbon-based chemistry, i. e. reductive coupling of two CS2 molecules that proceeds via
the development of the radical character at this carbon. Toward this goal, future work will
focus on the development of dinucleating macrocycles capable of tridentate coordination
to each nickel. Electron-rich Ni center in a tridentate ligand environment may be able to
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bind a heteroallene through the carbon only, which should subsequently lead to the
carbon-based chemistry.
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APPENDIX B SUPPLEMENTARY MATERIAL FOR CHAPTER 2
1.

1

H, and 13C NMR Spectra

Figure AB.1. 13C NMR spectrum of 6-(2,4,6-triisopropylphenyl)picolinaldehyde.

94

Figure AB.2. 1H NMR spectrum of 6-(2,4,6-triisopropylphenyl)picolinaldehyde.

95

Figure AB.3. 13C NMR spectrum of L1.

96

Figure AB.4. 1H NMR spectrum of L1.

97

Figure AB.5. 1H NMR spectrum of 1 in CD2Cl2. The spectrum was collected on the +100
to -100 ppm window; only the area that contains resonances is shown.

98

Figure AB.6. 1H NMR spectrum of 2 in CD2Cl2. The spectrum was collected on the +100
to -100 ppm window; only the area that contains resonances is shown.
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2. Mass Spectrometry

Figure AB.7. ESI-MS of 1. The peak corresponding to (1 – Br)+ is shown (below), along
with the theoretical prediction of the isotopic distribution (top)
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Figure AB.8. ESI-MS of 3. The peak corresponding to [3 – 2Br]2+ is shown (below), along
with the theoretical prediction of the isotopic distribution (top)
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Figure AB.9. ESI-MS of (1 + Formate).
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Figure AB.10. ESI-MS of (1 + Acetate).
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Figure AB.11. ESI-MS of (1 + Malonate).
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Figure AB.12. ESI-MS of (1 + Succinate).
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Figure AB.13. ESI-MS of (1 + Glutarate).
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Figure AB.14. ESI-MS of (1 + Formate and Oxalate).
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Figure AB.15. ESI-MS of (1 + Acetate and Oxalate).
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Figure AB.16. ESI-MS of (1 + Malonate and Oxalate).
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Figure AB.17. ESI-MS of (1 + Succinate and Oxalate).
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Figure AB.18. ESI-MS of (1 + Glutarate and Oxalate).
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3. UV-vis Spectroscopy

Figure AB.19. UV-vis spectrum of 1 (3.5 x 10-6 M in THF). The spectrum was collected
in the range 1000 – 450 nm.
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Figure AB.20. UV-vis spectrum of 2 (3.5 x 10-6 M in CH3CN). The spectrum was collected
in the range 1000 – 450 nm.
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Figure AB.21. UV-vis spectra of the titration of 1 with (NBu4)2[C2O4]. To a 3 mL solution
of 1 (20 mg) inTHF 0.1 mL fractions of (NBu4)2[C2O4] (10 mg) in 1 mL of CH3CN were
added until a stoichiometric amount was reached.
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Figure AB.22. UV-vis spectrum of 3 (1.7 x 10-6 M in CH3CN). The spectrum was collected
in the range 1000 – 450 nm.
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Figure AB.23. UV-vis spectrum of 4 (1.7 x 10-6 M in CH3CN). The spectrum was collected
in the range 1000 – 450 nm.
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Figure AB.24. UV-vis spectrum of the product of the reaction between 1 and formate.
The reaction was carried out by treating 1.5 mL of a 9.2 mM CH3CN solution of 1.5 mL of
a 9.2 mM CH3CN solution of formate. The spectrum was collected in the range 1000 –
450 nm.
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Figure AB.25. UV-vis spectrum of the product of the reaction between 1 and acetate.
The reaction was carried out by treating 1.5 mL of a 9.2 mM CH3CN solution of 1.5 mL of
a 9.2 mM CH3CN solution of formate. The spectrum was collected in the range 1000 –
450 nm.
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Figure AB.26. UV-vis spectrum of the product of the reaction between 1 and malonate.
The reaction was carried out by treating 1.5 mL of a 9.2 mM CH3CN solution of 1.5 mL of
a 9.2 mM CH3CN solution of malonate. The spectrum was collected in the range 1000 –
450 nm.
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Figure AB.27. UV-vis spectrum of the product of the reaction between 1 and succinate.
The reaction was carried out by treating 1.5 mL of a 9.2 mM CH3CN solution of 1.5 mL of
a 9.2 mM CH3CN solution of malonate. The spectrum was collected in the range 1000 –
450 nm.
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Figure AB.28. UV-vis spectrum of the product of the reaction between 1 and glutarate.
The reaction was carried out by treating 1.5 mL of a 9.2 mM CH3CN solution of 1.5 mL of
a 9.2 mM CH3CN solution of malonate. The spectrum was collected in the range 1000 –
450 nm.
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4. Determination of Binding Constant

Figure AB.29: The binding isotherms for Metal/Ligand mixtures.
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Figure AC.4. 1H NMR spectrum of 6.
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Figure AC.5. 13C NMR spectrum of 6.
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Figure AC.6. 19F NMR spectrum of 6.
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2. Mass Spectroscopy

Figure AC.14. Overall mass spectrum of 5.
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Figure AC.15. Mass spectrum of 5: peak attributed to [5-CF3SO3]+. Top: calcd for [5CF3SO3]+, 835.0118, Bottom: found, 835.0403.
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Figure AC.16. Mass spectrum of 5: peak attributed to [5-2(CF3SO3)]2+. Top: calcd for
[5-2(CF3SO3)]2+, 343.0299, Bottom: found, 343.0226.

138

Figure AC.17. Overall mass spectrum of 6.
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Figure AC.18. Mass spectrum of 6: peak attributed to [6-CF3SO3]+. Top: calcd for [6CF3SO3]+, 835.0118. Bottom: found, 835.0151.
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Figure AC.19. Mass spectrum of 6: peak attributed to [6-2(CF3SO3)]2+. Top: calcd for
[6-2(CF3SO3)]2+, 343.0299. Bottom: found, 343.0031.
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Figure AC.20. Overall mass spectrum of 7.
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Figure AC.21. Mass spectrum of 7: peak attributed to [7-CF3SO3]+.
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Figure AC.22. Mass spectrum of 7: peak attributed to [7-2(CF3SO3)]2+.
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Figure AC.24. Mass spectrum of 8: peak attributed to [8-CF3SO3] . Top: calcd for [8CF3SO3]+, 1003.1996. Bottom: found, 1003.2043.
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Figure AC.26. Mass spectrum of 9: peak attributed to [9-Br]+. Top: calcd for [9-Br]+,
821.0408. Bottom: found, 821.0231.
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Figure AC.27. Overall Mass spectrum of 10.
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Figure AII.28. Mass spectrum of 10: peak attributed to [10-O3SCF3]+. Top: calcd for [10O3SCF3]+, 777.0599. Bottom: found, 777.0700.
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3. Cyclic Voltammetry

Figure AC.29. Cyclic voltammogram of 5 in CH3CN, (0.1 M [NBu4](PF6), 25oC,
Platinum working electrode, 100 mV/s scan rate) 0.7 to -2 V range. High signal-to-noise
ratio is due to the fact that 5 is only sparingly soluble in CH3CN.

151

Figure AC.30. Cyclic voltammogram of 5 in CH3CN, (0.1 M [NBu4](PF6), 25oC, Platinum
working electrode, 100 mV/s scan rate), 0.8 to -2.6 V range.
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Figure AC.31. Cyclic voltammogram of 6 in CH3CN, (0.1 M [NBu4](PF6), 25oC, Platinum
working electrode, 100 mV/s scan rate), 0.8 to – 2 V range. High signal-to-noise ratio is
due to the fact that 6 is only sparingly soluble in CH3CN.
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Figure AC.32. Cyclic voltammogram of 6 in CH3CN, (0.1 M [NBu4](PF6), 25oC, platinum
working electrode, 100 mV/s scan rate), 0.8 to -3 V range.
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Figure AC.33. Cyclic voltammogram of 7 in DMF, (0.1 M [NBu4](PF6), 25oC, Platinum
working electrode, 100 mV/s scan rate), 1 to -2.8 V range.
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Figure AC.34. Cyclic voltammogram of 7 in DMF, (0.1 M [NBu4](PF6), 25oC, Platinum
working electrode, 100 mV/s scan rate), 1 to – 2.3 V range.
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APPENDIX D SUPPLEMENTARY MATERIAL FOR CHAPTER 4
1.

1

H, 19F, and 13C NMR

Figure AD.1 13C NMR spectrum of L5.
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Figure AD.2 1H NMR spectrum of L5.
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Figure AD.3. 13C NMR spectrum of L6.
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Figure AD.4. 1H NMR spectrum of L6.
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Figure AD.5. 13C NMR spectrum of L7.
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Figure AD.6. 19F NMR spectrum of L7.
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Figure AD.7. 1H NMR spectrum of L7.
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Figure AD.8. 13C NMR spectrum of Ni2(L1)(COD)2.
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Figure AD.9. 1H NMR spectrum of Ni2(L1)(COD)2.

165

Figure AD.10. 13C NMR spectrum of Ni2(L5)(13CS2)2.
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Figure AD.11.
observed.

13

C NMR spectrum of Ni2(L6)(13CS2)2. Only

13

C-labelled signals are
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Figure AD.12. 1H NMR spectrum of Ni2(L1)(CS2)2.

168

Figure AD.13. 13C NMR spectrum of the reaction between Ni2(L6)(13CS2)2 and
(FeCp2)(PF6).
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Figure AD.14. 1H NMR spectrum of L12.
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Figure AD.15. 13C NMR spectrum of L12.
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Figure AD.16. 1H NMR spectrum of Cu2(L1)(CH3CN)4(PF6)2.
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Figure AD.17. 13C NMR spectrum of Cu2L1I2.
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Figure AD.18. 1H NMR spectrum of Cu2L1I2.
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Figure AD.19. 1H NMR spectrum of Ni(L12)(COD).
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Figure AD.20. 13C NMR spectrum of Ni(L12)(COD).
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Figure AD.21. 1H NMR spectrum of NiL9(CS2).
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2. Mass Spectroscopy

Figure AD.22. Mass spectrum of [Ni2(L7)(COD)]. Peak attributed to
[Ni2(L4)(COD)]+. Above: calcd for [Ni2(L4)(COD)]+ 942.46, Below: found 942.44.
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Figure AD.23. MS of Ni2(L6)(CS2)2. Selected peak in the mass spectrum: calcd
for [Ni2(L2)(CS2)2 + H]+535.01, found 534.81.
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3. Cyclic Voltammetry
The electrochemical properties were determined by CV on a BAS Epsilon system.
Samples were prepared in anhydrous N,N’-Dimethylformamide or in anhydrous
tetrahydrofuran with tetrabutylammonium hexafluorophosphate (0.1 M) as the
supporting electrolyte. The redox potentials were determined versus an Ag/Ag+
reference electrode. The Fc/Fc+ potential was determined vs. the Ag/Ag+ electrode
using the average of ten observations.

Figure AD.24. Cyclic voltammogram of L1 in DMF, (0.1 M [NBu4](PF6), 25oC, Platinum
working electrode, 100 mV/s scan rate). The solubility of L1 is very limited in DMF.
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Figure AD.25. Cyclic voltammogram of Ni2(L1)(COD)2 in DMF, (0.1 M [NBu4](PF6),
25oC, Platinum working electrode, 100 mV/s scan rate).
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4. Computational Details
Electronic structure calculations were carried out using Density Functional Theory
(DFT) as implemented in Gaussian 09.39 Geometry optimizations were performed at the
B3LYP/LANL2DZ/6-31G(d,p)40-47 level of theory with no symmetry constraints. All
optimized structures were confirmed to have stable wavefunctions,47 and to be local
minima by analyzing the harmonic frequencies.47

182

Figure AD.26. Frontier orbital diagram of 20. Doubly occupied and unoccupied orbitals
represented by bold and normal lines, respectively. All orbitals are plotted using an
isosurface value of 0.05
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Dinuclear metal complexes provide a route to interesting structure and reactivity.
Two common uses of dinuclear metal complexes are sensing and activation of small
molecules. Herein we describe a series of dinuclear metal complexes capable of sensing
of oxalate and activation of carbon disulfide.
Sensing of oxalate is of great interest because high oxalate concentration
(hypooxaluria) is a major cause of kidney stones. Dinuclear metal complexes can act as
sensors for oxalate because the oxalate can bridge between the metal centers. Herein
we describe a colorimetric oxalate sensor capable of regeneration. Upon addition of
oxalate

to

a

pink

solution

of

a

L1Ni2Br4

complex

(L1=

(1E,1′E)-N,N′-(1,4-

phenylenebis(methylene))bis(1-(6-(2,4,6-triisopropylphenyl)pyridin-2-yl)methanimine) to
a green solution of L1Ni2(C2O4)Br2. Due to this color change UV-vis titration was used to
determine the binding constant of oxalate to be 5.2(5) x 102 M-1. Addition of CaBr2 to the
green solution leads to the regeneration of the sensor by precipitation of Ca(C2O4).
Therefore we report the first example of an oxalate sensor capable of colorimetric
detection of oxalate coupled with regeneration.
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The synthesis of di-zinc macrocycles featuring bis(imino)pyridine chelating units
linked by p-xylylene or m- xylylene linkers. Characterization of the compounds by NMR
and X-ray structure determination revealed that the complexes were highly symmetrical
(C2v or D2h). Cyclic voltammertry revealed that the combination of a redox-noninnocent
ligand with a redox inactive metal stilled allowed the ligand to accept electron density.
Oxalate extraction was unsuccessful with acetic acid, EDTA, and TMSCl. Attempts at
extraction with CaBr2 lead to transformation of μ2-κ2,κ2-bound oxalate into the μ2-κ1,κ2bound form. The addition of aqueous HCl to a macrocyclic complex showed oxalate free
macrocycles by ESI-MS but any product was only transient and unable to isolated.
Activation of CS2 is of great interest because it is isoelectronic to CO2 and thus
should similar reactivity. Herein we report the synthesis of a series of di-Ni complex
capable of binding and activating CS2. DFT and X-ray revealed that the bound CS2 was
two electron reduced, thus in order to induce reductive coupling of the two CS2 fragments
oxidation was attempted with FeCp2(PF6). This however lead to liberation of the
dinucleating ligand. Di-Cu(I) complexes were also synthesized however they showed no
reactivity with CS2. More soluble mononuclear Ni(0) analogues were also synthesized
that were also able to bind and activate CS2 however, reduction or oxidation by one
electron yielded liberation of the free ligand as in the dinuclear complexes.
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